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Abstract 
 
 Schizophrenia is neurodevelopmental disorder characterized by a three-factor structure 
consisting of positive, negative, and disorganized symptoms. In addition to the symptoms of the 
disorder, individuals also present with several cognitive deficits. Individuals diagnosed with 
schizophrenia have also been observed to have minor physical anomalies (MPAs), which are 
slight differences in the dermis, cartilaginous, and bone structures. The research connecting these 
MPAs to symptoms and cognitive deficits is limited. Most studies have examined the total 
number of MPAs present, and not the severity by which they are expressed, and ratings of 
symptoms. This research aimed to link the severity-specific MPAs seen in schizophrenia to the 
severity of specific symptoms and cognition by quantitatively measuring MPAs. This study did 
not find significant relations between MPA severity and symptom ratings nor cognition. 
Interesting trends were present for hair whorl placement and the gap between the first and second 
toes. Post-natal injuries in MPA areas were not assessed. This study used hand tools for the 
measurement of MPAs and missing data for individuals reduced the sample size for individual 
tests. The sample size of this study was found to be underpowered to find significant differences 
if any exist. 
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Introduction 
Minor Physical Anomalies and Specific Symptoms of Schizophrenia  
Schizophrenia is a debilitating disorder that afflicts approximately 1% of the population. 
This disorder has an onset in early adulthood and affects all facets of an individual’s life, 
including social, occupational, and personal functioning. The neurodevelopmental model of 
schizophrenia (Weinberger, 1987) posits that both genetic and environmental factors contribute 
to structural brain changes during the in-utero development of a fetus and continue through life. 
These contributing factors are believed to predispose an individual to developing schizophrenia. 
Minor physical anomalies (MPAs) are subtle differences of the head, hands, and feet that have 
been shown to be biomarkers of neurodevelopment (O’Callaghan et al., 1995; Green, Bracha, 
Satz, & Christenson, 1994; McGrath, van Os, Hoyos, Jones, Harvey, & Murray, 1995). Previous 
research has found that people with schizophrenia have increased MPAs (e.g., Lal & Sharma, 
1986; McGrath et al., 2002), but MPAs have not been linked to specific symptoms or cognitive 
deficits in people with schizophrenia.  
MPAs on different parts of the body emerge at specific points during embryogenesis and 
in utero development, which may provide clues as to when development was disrupted. As such, 
MPAs may serve as a “fossil record” of problems in development (Cheung et al, 2011), meaning 
they are likely markers of abnormal development occurring during the gestation process. MPAs 
in schizophrenia are likely due to genetic or teratogenic factors during in utero development. 
Determining which of the MPAs are more strongly associated with the symptoms and cognitive 
deficits of schizophrenia, may help to establish a clearer time frame of when a fetus is at risk for 
developing the disorder. By examining the severity in the expression of MPAs, the associated 
symptoms, and cognitive deficits, this research can lead us to a better understanding of the 
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developmental course by pointing to specific in utero developments that predispose individuals 
to develop schizophrenia. 
MPAs are subtle variations in soft tissue, cartilaginous, and bony structures that are the 
result of a mix of genetic and environmental factors operating prenatally. These physical 
anomalies are considered biomarkers, as they are not themselves risk factors for the development 
of schizophrenia rather manifestations of the underlying disease liability (Lenzenweger, 2013, 
Gottesman & Gould, 2003). They are believed to be due to an interaction of genetics and 
teratogens during the developmental period when the brain and afflicted areas of the body are 
developing in tandem. MPAs seen in the face, hands, and feet are more common, but are also 
present on the head and mouth regions. An impressive body of research has found that MPAs are 
more common in people with schizophrenia than in the general population (e.g., Aksoy-Poyraz, 
Poyraz, Turan, & Arikan, 2011; Gualtieri, Adams, Shen, & Loiselle, 1982; Ismail, Cantor-Graae, 
& McNeil, 2000; Lin et al., 2012; Raedler, Knable, & Weinberger, 1998, O’Callaghan et al, 
1995) with some estimates of MPAs being twice as common among people with schizophrenia 
(Lohr & Flynn, 1993). In addition, longitudinal studies have found that MPAs measured at age 
10-13 are a robust predictor of the development of schizophrenia later in life (Golembo-Smith et 
al., 2012). Some research shows differences in MPAs among non-affective psychosis patients, 
affective psychosis patients, and healthy controls. First-episode psychosis patients present with 
differences in overall facial symmetry, symmetry of the orbital landmarks, and lowered Frankfurt 
lines (craniofacial measurement from the opening of the ear canal to the lower ocular orbit), and 
affective psychosis participants had lowered eye fissures compared to healthy controls (Lloyd et 
al., 2008). This research shows differences in MPAs between the first-episode psychosis patients 
and individuals with affective psychosis. Much of this research has treated MPAs as a 
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categorical presence or absence variable, as opposed to a continuous variable that takes into 
account the severity of the expression of MPAs. If MPAs are a marker of neurodevelopment, it is 
possible that more severe disturbances in neurodevelopment could result in more severe MPAs. 
Thus, the current research measured MPAs dimensionally to examine whether severity of MPAs 
is related to the severity of symptoms and cognitive deficits in people with schizophrenia.  
 Along with the varying physical expression of MPAs, symptoms of schizophrenia also 
vary among individuals with the disorder. A long line of research suggests that schizophrenia is 
comprised of three symptom factors: positive, negative, and disorganized (Arndt, Alliger, & 
Andreasen, 1991; Miller, Arndt, & Andreasen, 1993). Positive symptoms refer to psychosis, 
characterized by delusions (false fixed beliefs that are resistant to change) and hallucinations 
(sensory experiences of perception without corresponding stimuli). These symptoms are 
considered positive symptoms because they are additional experience for the person with 
schizophrenia that are absent in non-afflicted individuals. Negative symptoms are altered or 
reduced emotional responses; including blunted affect (a reduction in the expression of 
emotions), speech deficits, social anhedonia (lack of enjoyment in social situations), and 
avolition (lack of motivation) (Andreasen, 1982). Negative symptoms are referred to as negative 
because they represent deficits in functioning when compared to non-afflicted individuals. 
Disorganized symptoms involve confused thinking that may lead to difficulty communicating 
(Carson, 2000). Disorganized symptoms include formal thought disorder, bizarre and/or 
disorganized behavior, and inappropriate affect.   
MPAs seen in schizophrenia are due to both genetic and environmental factors beginning 
at conception and lasting through life. When these genetic factors and teratogens produce brain 
abnormalities, they also modify other parts of the body, including the head, hands, mouth, face, 
Running head: Minor Physical Anomalies and Specific Symptoms of Schizophrenia 11 
and feet. This phenomenon is also seen in Fetal Alcohol Syndrome. The influence of alcohol (a 
teratogen) on the developing fetus manifests a distinctive pattern of abnormal facial features 
(Mattson, Schoenfield, & Riley, 2001).  Thus, MPAs may serve as an external biomarker for 
disrupted neurodevelopment. Research shows there are two possible explanations to account for 
the link between MPA and schizophrenia: genetic abnormalities and retinoid interruption. One 
genetic syndrome linked to both schizophrenia and MPAs is velocardiofacial syndrome (VCFS). 
Estimates of 25-37.5% of patients with VCFS have been diagnosed with schizophrenia or 
schizoaffective disorder (Cohen et al., 1999; Shprintzen, Goldberg, & Golding-Kushner, 1992; 
Pulver et al., 1994; Murphy Owen, 1997). Many others are thought to meet criteria for 
schizophrenia but cannot be diagnosed because IQ can be severely diminished in these 
individuals and self-report of symptoms becomes unreliable (Chow, Bassett, & Weksberg, 
1994).  
VCFS is a genetic disorder characterized by MPAs, primarily in the facial appearance, 
and is associated with heart defects and brain abnormalities. Facial MPAs commonly observed in 
VCFS patients include elongated face, hypertelorism, bulbous nose (Gothelf et al., 1999), cleft 
palate, and bone abnormalities (Ryan et al., 1997). Genetic deletions of the 22q11.2 genetic locus 
are the leading cause of the VCFS. Observations of VCFS patients having a high susceptibility to 
schizophrenia have lead researchers to link the deletion of genetic locus of 22q11.2 to the 
developmental processes of schizophrenia (Carlson et al., 1997; Chow, Bassett, & Weksberg, 
1994; Cohen, Chow, Weksberg, & Bassett, 1999; Reis et al., 2013). It is believed the deletion at 
the 22q11 locus disrupts the rostral crest (the fetal area that develops the face and head), or the 
cells with which the neural crest (migratory cells that differentiate into facial cartilage, bone) 
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interacts, at a critical phase of organogenesis (Scambler, 2000).  Thus, VCFS is a risk factor for 
schizophrenia that is marked by MPAs.   
 The second developmental avenue associated with schizophrenia and the development of 
MPAs is retinoid interruption (Goodman, 1998; Anchan, Drake, Haines, Gerwe, & Lamantia, 
1997). Retinoids interact in an intricate way with the body by a complex genetic cascade that 
transforms beta carotene into retinoic acid, which influence the expression of target genes and 
can lead to the development of MPAs. Genetic causes (Goodman, 1995) and/or environmental 
factors including teratogens, such as maternal influenza, rubella, dietary insufficiency, stress, 
urban birth and winter birth deregulate the retinoid pathway (Brown, 2006; Waddington, Lane, 
Larkin, O’Callaghan, 1999; Watson, Mednick, Huttunen, & Wang, 1999). During the 9-12 week 
time period of in utero development, a fetus is developing cells that will eventually differentiate 
into limb buds, the epidermis, and neurons (Sperber, 2001). The retinoid pathway is also 
beginning to develop at this time. When one of the above mentioned teratogens are present 
during this critical period, the fetus has a higher chance of developing retinoid pathway 
abnormalities, which can lead to dysfunction in brain development (Anchan, Drake, Haines, 
Gerwe, & Lamantia, 1997; Chiang et al., 1998; Goodman, 1995) and the development of both 
MPAs and schizophrenia.  
 As can be seen in Table 1, several studies have examined the relations between MPAs, 
the symptoms of schizophrenia, and cognitive abilities, but these results are mixed. Some 
researchers found no associations between MPAs and symptoms. Aksoy-Poyraz (2011) found 
there to be no association between MPAs and the Scale for the Assessment of Negative 
Symptoms (SANS), the Scale for the Assessment of Positive Symptoms (SAPS) scores nor the 
disorganized dimensions of the disorder. No differences were found between people with 
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schizophrenia and bipolar disorder (Lohr & Flynn, 1993) and no differences between individuals 
with non-affective (no mood disturbances) and affective (mood disturbances present) psychosis 
(McGrath et al., 2002).  
Other researchers examining the associations between MPAs and symptoms have found 
the total number of MPAs to be higher in individuals with schizophrenia compared to people 
without a history of mental illness (i.e., healthy controls; Green, Gaier, Ganzell, & Kharabi, 
1989; Gaultieri, Adams, Shen, & Loiselle, 1982; Schiffman, Ekstrom, LaBrie, Schulsinger, 
Sorensen, & Mednick, 2002). Other work has found that people with schizophrenia have more 
MPAs than people with bipolar disorder (Green, Satz, Christenson, 2004; Trixler, Tényi, Csábi, 
& Szabó, 2001), and that people with bipolar disorder have more MPAs than healthy controls 
(Akabealiev, Siklov, & Matatkov (2014). People with schizophrenia, but without a family history 
of schizophrenia (sporadic schizophrenia), have higher levels of MPAs than do people with 
schizophrenia and a family history (Griffiths et al., 1998). The findings from Griffiths et al. 
(1998) suggest that sporadic schizophrenia is likely a congenital disorder caused by teratogens 
influencing fetal development.   
Some research shows differences in MPAs between first-episode psychosis patients, 
affective psychosis patients, and healthy controls (Lloyd et al., 2008). The research demonstrates 
first-episode psychosis patients have higher number of MPAs and can be differentiated from 
affective psychosis (with slightly fewer MPAs) and healthy controls with the fewest number of 
MPAs. This research shows a link between the number of MPAs and the severity of psychosis. 
These studies also show the link between higher MPA scores and the pathology commonly 
observed in schizophrenia. More specifically, significant correlations have been found between 
total number of MPAs and negative symptoms (O’Callaghan et al. 1995), especially MPAs of the 
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mouth (Compton et al, 2007). Compton et al. (2007) also found MPAs of the mouth and feet to 
be associated with positive symptoms, and MPAs of the ears to be associated with general 
severity of psychopathology. As can been seen, links between MPAs and the symptoms of 
schizophrenia are mixed and contradictive. Although researchers have long been interested in 
MPAs, most of this has looked at the global associations of total number of MPAs and the two 
(positive and negative) or three (positive, negative, and disorganized) symptom dimensions 
rather than looking at the specific MPAs or groups of MPAs and specific symptoms of 
schizophrenia. Moreover, most of these studies have use dichotomous measurements of the 
MPAs. 
The links between MPAs and cognitive abilities and neurological differences in 
individuals with schizophrenia are also mixed. A few researchers have reported no significant 
relationship between MPAs and IQ (Rosen & Weller, 1973; Alexander, Mukhurerjee, Richter, & 
Kaufmann, 1994), and no relationship between the curvature of the fifth finger and IQ (Hope, 
Bates, & Gow, 2012). In addition, associations were not found between MPAs and information 
processing tasks (Degraded-Stimulus continuous performance task, span of apprehension, 
backward masking procedure, the Pin Test, and Wisconsin Cars Sorting Task) (Green, Bracha, 
Satz, & Christenson, 1994). Similarly, no significant correlations were found between MPAs and 
neurological functioning (O’Reilly, Lane, Cernovsky, & O’Callaghan, 2001), and premorbid 
functioning (Alexander et al, 1994).  
Although no associations have been found in some studies, others have found significant 
associations between MPAs and cognitive abilities. MPAs have been shown to have a negative 
association with receptive vocabulary in children 6-7 years of age (Rosenberg & Weller, 1973), 
memory of word-pairs (delayed auditory memory) (Ismail, Cantor-Graae, & McNeil, 2000), 
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visual immediate memory and visual delayed memory, and general memory (Mittal & Walker, 
2011). Critically, all of the studies that have examined MPAs and cognitive symptoms have 
measured MPAs as a dichotomous variable, and no studies have used a comprehensive battery of 
cognitive functioning to determine which aspects of cognitive functioning are related to MPAs 
and which are not. In the current study, the National Institute of Mental Health’s (NIMH’s) 
Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) 
Consensus Cognitive Battery (MCCB) was used to evaluate cognition (Nuechterlein et al., 
2008). The MCCB was developed as a comprehensive measure of cognitive functioning that taps 
all critical domains that are impaired in schizophrenia. The domains of cognition selected for this 
battery include speed of processing, verbal learning, working memory, reasoning and problems 
solving, social cognition, and attention/vigilance. To date no research concerning MPAs has used 
the MCCB.  
 In addition to limited research examining the relations among MPAs and specific 
symptoms and cognitive deficits, much of this research has focused on the presence of the minor 
physical anomalies and not the relative severity of them. For example, when observing the 
presence of MPAs like syndactyly (webbed toes) the presence of the webbing was recorded as 
present or not, the length the webbing reaches down the toes was not recorded (with the 
exception of the Lane et al. (1997) scale). Lane et al. (2007) worked to improve the measurement 
of the MPAs by taking quantitative measurements, and then categorized them into three groups 
based on the severity of the expression compared to the sample used. Since schizophrenia is also 
thought to vary widely in severity (e.g., American Psychiatric Association, 2013l; Van Os, 
2000), treating MPAs as a dimensional variable may provide a more appropriate analytic 
strategy.  By measuring the individual MPAs in a quantitative manner and measuring the 
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individual symptoms on a scale, this research has the ability to strengthen our understanding of 
the developmental pathway of schizophrenia by providing information about the severity of 
MPAs and their association to the severity of symptoms and cognitive deficits.   
 The current research focused on the severity of many MPAs and the different facets of 
symptoms based on the 3 factor model developed by Arndt et al. (1991) and Miller et al. (1993) 
and the cognitive deficits observed in schizophrenia. The first goal of the current research was to 
replicate previous findings that people with schizophrenia have a higher quantity and more 
severe MPAs than healthy controls. The second goal was to examine whether severity of MPAs 
is associated with positive, negative, and disorganized symptoms among people with 
schizophrenia. Finally, the third goal was to test whether the severity of MPAs is associated with 
the severity of cognitive deficits.  
Method 
Participants 
 Participants were recruited from the island of Oahu. Individuals in the “Healthy Control” 
(HC) group were recruited via www.craigslist.com (a publicly accessible website) and flyer 
boards at local public libraries. Individuals that responded to the posting were administered a 
brief phone screen to determine their eligibility in the study. The phone screen consisted of 
questions concerning ethnicity, age, gender, history of mental health of the individual and 
family, history of drug use, and history of traumatic brain injury. Individuals who did not report 
a history of mental health concerns, drug abuse, or traumatic brain injury were selected for the 
study. The HC group consisted of 31 individuals (48.38% female; 48.38% Caucasian, 22.58% 
mixed ethnicity) with a mean age of 42.56 (SD = 14.05; see Table 2 for a full description of the 
demographic variables).  
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 Individuals were recruited for the schizophrenia group through fliers placed at local 
mental health providers, including Safe Haven supportive housing and Clubhouses supported by 
Hawaii Department of Health Adult Mental Health Division. Individuals that responded to the 
fliers were screened with a brief phone interview to determine their eligibility in the study. 
Eligibility for this study required the schizophrenia group to have a current diagnosis of 
schizophrenia or schizoaffective disorder with no current drug abuse. The schizophrenia group 
consisted of 47 individuals (46.80% female; 27.65% Caucasian, 19.14% Hawaiian) with a mean 
age of 49.32 (SD = 10.34; see Table 2 for a full description of the demographic characteristics). 
There were no statistically significant differences between the groups for gender, χ2 (1) < 
0.001, p = 0.99, and ethnicity, χ2 (8) = 12.25, p = 0.14. The schizophrenia group was 
significantly older, t (77) = 2.46, p = 0.016, than the Healthy Control group (M = 49.32, SD = 
10.34; respectively; see Table 3 and Table 4).  
Materials 
Measurement of Minor Physical Anomalies.  
 The measurement of MPAs is a novel scale informed by previous research conducted in 
the area of MPAs. Six regions of the body were observed: head, eyes, ears, mouth, hands, and 
feet. The six regions of the body observed are based on the Waldrop Scale developed in 1962-64 
with 74 “normal” Caucasian 2.5-year-old children (43 male). This scale was later revised and is 
now called the Waldrop-Halverson Scale (Waldrop & Halverson, 1971). Modifications to this 
scale have been used by many researchers (Lane et al., 1997, Yoshitsugu, 2006) in the 
investigation of MPAs in persons with schizophrenia. Though this scale was originally 
developed for use on Caucasian individuals, Lin et al. (2012) found significant results using this 
scale in a Chinese population. The results from the study indicate the anomalies are universal and 
can be observed in individuals from different ethnic backgrounds. 
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 Based on this scale, the six regions of the body were examined. These regions included: 
the head, ears, mouth, eyes, hands, and feet. The Waldrop-Halverson Scale uses mostly 
qualitative identification of the MPAs. In order to improve the understanding of the relationship 
of MPAs and the symptoms of schizophrenia, similar tools and methods were described by Lane 
et al. (1997). These modifications are designed to quantify and elaborate on the presence of the 
physical anomalies. Below are descriptions of all the anomalies measured and the methods by 
which the measurements occurred.  
Head. The anomalies measured in the head region are as follows: hair whorls, head 
circumference, and facial height. Hair whorls are patches of hair found on most people where the 
hair on the head grows in a different direction than the rest of the hair. They are normally found 
on the crown of the head and most people have only one. The Waldrop-Halverson Scale 
(Waldrop & Halversen, 1971) code for this phenomenon is based solely on the presence of more 
than one whorl or the lack of whorls. For the purpose of further assessing the developmental 
processes associated with schizophrenia, hair whorls were assessed in four ways for the purpose 
of this research. The first observation was to decide whether the hair whorl can be accurately 
observed. As cultural norms are for women to have longer hair and some men have longer hair, 
the characteristics of the hair whorls were not observable, it was noted if the presence of hair 
whorls could not be observed. The second characteristic observed was the total number of whorls 
present. A visual observation of the head was conducted and the total number of whorls was 
recorded. The determination of the number of hair whorls required there to be clear location from 
which the participant’s hair originated. These locations were identified by a clear swirl pattern. 
The third characteristic observed was the direction of the hair whorl. The direction of the whorl 
was recorded as clockwise, counter-clockwise, or indeterminable. Finally, the fourth 
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characteristic measured was the position of the whorl in relation to the midline of the body. A 
visually inspection of the participant’s whorl placement was used to determine its placement. 
The position of the hair whorl was recorded as centered, left-of-center, or right-of-center. To 
determine if the whorls were not on the midline, the center of the whole had to be more than .25 
inches from the midline of the head. 
The circumference of the head was measured by extending a fabric measuring tape 
starting at the glabella (area of the forehead between the eyebrows), continuing over the 
supraorbital ridge, around the back of the head above the adjoinment of the upper ear to the 
occiput posterior, continuing back across head over the adjoinment of the other ear, across the 
supraorbital ridge and back to the glabella. The total circumference of the head was recorded to 
the nearest millimeter.  
The measurement of facial height was based on two measurements along the midline of 
the face. The first was measured from the glabella to the top of the philtrum (where columella of 
the nose meets the upper lip). The second was from the top of the philtrum to the base of the 
chin. These two measurements were done using calipers. A ratio of facial height was created by 
dividing the height of the midface (glabella to top of philtrum) by the height of the lower face 
(philtrum to chin). The addition of these measurements to the MPA assessment was based on 
findings from Lane et al. (1997) showing that individuals with schizophrenia tend to have shorter 
middle sections of the face. 
Ears. Anomalies in the ears were noted if they were low set, have adherent lobes, were 
malformed, asymmetrical, and the amount they protrude from skull. The placement of the ears 
was measured by placing a fabric measuring tape on the bridge of the nose, across the eye to the 
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outer corner of the eye, then extended back to the top juncture of the ear. The distance between 
the measuring tape and the actual juncture of the ear was measured using calipers.  
Adherent lobes were defined as lobes that are attached to the side of the head, they were 
recorded as attached or unattached. This measurement required that the lobes be fully attached, 
meaning there must not be a cleave present between the side of the head and the earlobe to be 
recorded as attached.  Malformed ears were defined as ears that do not exhibit the formation that 
is seen in the general populace. The measurement of the malformation of the ear was based on 
gross-malformation. It involved a visual inspection of the ears and the investigator made the 
determination if gross malformation was present. This determination was not based on a specific 
measurement of the ear due to the variation in ear shapes present in all humans. To determine 
asymmetry of the ears, the height of each ear was recorded. The measurement was done with 
digital calipers reaching from the lowest part of the ear to the highest part of the ear that creates 
the largest distance.  
The protrusion of the ears from the skull was measured using the calipers. The distance 
from the pinna of the ear to the skull was recorded. This measurement was recorded to the 
nearest millimeter.  
Mouth. The measurements taken from the mouth area were palatal shape, the presence of 
palatal ridges, furrows of the tongue, smooth or rough spots, and bifid tongue. The measurement 
of the palatal shape was consistent with the Waldrop-Halverson scale. This measurement 
includes the steepling of the roof of the mouth, and the general shape of the roof. A visual 
inspection determined the presence of a U-shaped palate, a steepled palate with a flattened apex, 
or a steepled palate with a V-shaped apex. Visual aids were provided to improve the rater 
accuracy of the palatal shape. 
Running head: Minor Physical Anomalies and Specific Symptoms of Schizophrenia 21 
The presence of palatal ridges was determined by visual examination of the roof of the 
mouth. Ridges were coded as present if they could be observed from behind the first bicuspid of 
further back, toward the throat. These ridges were also counted from the first bicuspid toward the 
back of the mouth and the total number of ridges was recorded. 
The anomalies of the tongue were measured and coded based on a visual inspection of 
the participant’s tongue. The presence of furrows was recorded as present if fissures were visible. 
The general location of the fissures was also recorded as on the midline or not. Rough and/or 
smooth spots were coded as present if the investigator easily views these anomalies. The last area 
of the tongue to be inspected was the tip. A bifid tongue was marked as present if an easily 
visible split along the midline of the tip of the tongue is present.  
Eyes. The anomalies observed from the eye region were abnormal epicanthus covering, 
strabismus, and hypertelorism. Anomalies in the epicanthus were observed where the upper and 
lower lids join the nose, this point of union has varying degrees of coverage. The Waldrop-
Halverson Scale coding system was used in this measurement as well. A visual inspection of the 
epicanthus was done to determine its coding. The coding for the epicanthal coveraged was 
determined by the coverage of the caruncula (fleshy, usually pink colored, area in the inner 
corner of the eye, where the tear ducts secrete tears). The degree to which the epicanthus covers 
the caruncula was recorded in three ways. The first is no coverage of the caruncula (completely 
visible all the way to the inner corner of the eye, the second is partial coverage (any amount of 
the caruncula is covered), and the third is complete coverage of the caruncula (not visible). A 
visual inspection of this area was conducted and the expression of the epicanthus was recorded 
based these three levels of measurement.  
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Strabismus was determined by a visual inspection performed by the investigator. The 
participant was asked to look straight forward at the investigator, if the eyes appear to be looking 
in different directions the presences of strabismus was recorded. In individuals with strabismus, 
the type was recorded as either esotropia (one or both eye look toward the midline), exotropia 
(one or both eyes look to the lateral), or hypertopia (one of the eyes look up or down). 
Hypertelorism is a broadening of the space between the eyes. Digital calipers were 
applied to the lacrimal punctum (meeting of the upper and lower eyelids and the epicanthus) to 
determine the distance between the eyes. This area is also called the inner intercanthal distance. 
The distance between the eyes was recorded to the nearest millimeter. 
Hands. The hands were observed for a curved fifth finger (pinky finger), a single 
transverse palmar crease, and an index finger that is longer than the middle finger. A curved fifth 
finger was defined as a finger that bows away from the fourth finger and curves back to meet the 
fourth finger. A single transverse palmar crease was defined by the individual presenting their 
palm to the researcher and the number of long creases that extend across the palmar surface were 
counted. If only one is present, the individual was coded as having the anomaly.  
The difference between the index and middle finger was measured by placing the calipers 
along the side of the fingers. Two measurements were taken. These measurements were the 
length of each finger. Measurements were taken of the index finger from the base to the tip along 
the side it next to the middle finger. The length of the middle finger was also recorded from the 
base to the tip, along the side next to the index finger. The length of each was recorded to the 
nearest millimeter. These two values were recorded and the difference between them was 
calculated by subtracting the index finger length from the middle finger length. 
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 Feet. The last region of the body measured was the feet. The anomalies observed from 
this region were partial syndactyly (webbing) and the gap between the first toe (big toe) and the 
second toe. Four measurements of the toes were taken to quantify the presence of syndactyly. 
The four measurements were the medial and lateral lengths of the second and third toes. With the 
participant in a seated position with feet flat on the floor, the digital calipers were placed against 
the webbing between the first and second, second and third, and third and fourth toes. The length 
of each side of the second and third toes was measured and recorded. Syndactyly was recorded 
as a ratio of the length of the exterior of the second toe and the exterior of the third toe. Based on 
a visual inspection, the presence of webbing was determined. The investigator observed if 
webbing was present between the second and third toes and recorded whether or not webbing we 
visually observable. The gap between the first and second toes was measured using calipers. The 
participant was in a seated position with feet flat on the floor. The calipers were placed in the 
widest part of the gap between the first and second toes, and the width of the gap was recorded to 
the nearest millimeter. 
In order to assure that the MPAs were assessed in the same way by all raters, the primary 
investigator provided training to the other researches involved in gathering the data for the 
project. The training consisted of explaining what each of the MPAs were and how they should 
be measured and recorded. The methods of measuring the MPAs were also taught by performing 
the measurements on a volunteer not participating in the study itself. The other investigators 
were also observed by the primary investigator while completing the MPA assessment on at least 
two of the study participants to improve accuracy in the measurements.  
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Diagnosis and Symptom Ratings. 
Scheduled Clinical Interview for DSM-IV Mental Disorders (SCID-I). The SCID-I is a 
well-known diagnostic tool used by clinicians to effectively assess symptoms and diagnose 
individuals with mental disorders as listed in the Diagnostic and Statistical Manual for the 
Diagnosis of Mental Disorders (DSM). This measure has been used as the “gold standard” for 
the diagnosis of mental disorders in many studies (e.g. Shear et al, 2000; Steiner et al, 1995). 
Inter-rater reliability for the SCID-I is reported to be between 0.61 and 0.83 (Lobbestael, 
Leurgans, & Arntz, 2011). Validity of the SCID was assessed by Basco et al. (2000) and found 
kappa values ranging from 0.76 - 0.78 for diagnosis comparisons between standard interview 
methods and SCID diagnoses with the aid of medical records.   
Positive and Negative Symptom Scale (PANSS).  The Positive and Negative Symptom 
Scale (PANSS; Kay, Fiszbein, & Opler, 1987) is a 30-item 7-point Likert-type scale used to rate 
schizophrenia symptoms.  The PANSS assesses common symptoms of schizophrenia within 
three symptom cluster scales, including Positive Symptoms, Negative Symptoms, and General 
Psychopathology.  One of the three graduate student experimenters determined PANSS scores 
for each schizophrenia participant, using the Structured Clinical Interview for the PANSS (SCI-
PANSS). The reliability of symptoms ratings between individual raters was tested through a 
intraclass correlation (ICC) for the scores on the SCI-PANSS ratings and the three domains for 
the measure (positive, negative, and general symptoms). The ICC for all of the symptoms was 
found to be 0.776, indicating a high level of agreement for all of the rated symptoms. The 
domains of the measure were also found to have high intraclass correlations; Positive = 0.823, 
Negative = 0.778, and General = 0.749. These high correlations indicate that all raters were 
reliably rating each participant at the same level of symptom severity as the other raters. The 
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ratings from the SCI-PANSS and the BPRS have the same minimum (0) and maximum (7) range 
of scores and the scales from the BPRS are directly used in the SCI-PANSS. Therefore, it was 
reasonable to convert the SCI-PANSS ratings into BPRS ratings for the purposes of this study. 
Cardiff Anomalous Perceptions Scale (CAPS) (Bell, Halligan, & Ellis, 2006). The 
Cardiff Anomalous Perceptions Scale is a 32-item self-report questionnaire. The CAPS uses 
three subscales to measure distress, intrusiveness, and frequency of anomalous experiences. For 
each of the 32 items endorsed by the individual they are asked to rate distress, intrusiveness, and 
frequency on a 5-point Likert scale. The ranges of scores for the subscales are as follows: 
distress (0=Not at all distressing to 5=Very distressing), intrusiveness (0=Not at all distracting to 
5=Completely intrusive), and frequency (0=Happens hardly at all to 5=Happens all the time). 
Reliability of the CAPS is estimated with Cronbach’s alpha coefficient equal to .87. A test-retest 
procedure was conducted and a Cronbach’s alpha coefficient was estimated to be .92. The test-
retest analysis of the measure found a Pearson correlation for the total score of r = .77. The 
subscale Pearson correlations are as follows: distress = 0.779, intrusiveness = 0.783, and 
frequency = 0.778. The CAPS validity was assessed by correlating it with the Oxford and 
Liverpool Inventory of Feelings and Experiences (O-LIFE), Peters Delusion Inventory (PDI), 
and Revised Launay-Slade Hallucinations Scale (RLSHS). Significant correlations (p < .05) 
were found for all scales and subscales except the Introvertive Anhedonia subscale of the 
RLSHS, demonstrating good discriminate validity of perceptions and not schizotypy in general 
(Bell, Halligan, & Ellis, 2006). 
Peters Delusion Inventory (PDI). The Peters Delusion Inventory is a 40-item self-report 
questionnaire. The PDI uses three subscales to measure distress, preoccupation, and conviction. 
For each of the 40 items endorsed by the individual they are asked to rate distress, preoccupation, 
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and conviction on a 5-point Likert scale. The range of scores for the subscales are as follows: 
distress (0=Not at all distressing to 5=Very distressing), preoccupation (0=Hardly ever think 
about it to 5=Think about it all the time), and conviction (0=Don’t believe it’s true to 5=Believe 
it is absolutely true). Reliability of the PDI was estimated to be Cronbach’s α = 0.88. Test-retest 
reliability was estimated to be Pearson’s r = 0.82 (p < 0.001). The construct validity of PDI has 
been examined with other measures of psychotic and psychotic-like experiences including 
Schizotypal Personality Scale, Magical Ideation Scale, and the Delusions Symptom-State 
Inventory; yielding high correlations.  
Brief Psychiatric Rating Scale (BPRS) (Overall & Gorham, 1962). “The Brief 
Psychiatric Rating Scale was developed to provide a rapid assessment technique suited to the 
evaluation of patient change” (Overall & Gorham, 1962). The BPRS consists of 16 items scored 
on a 7-point Likert scale, 0=Not present to 7=Extremely Severe. The interviewer determines the 
scores. Overall & Gorham (1962) recommend at least two raters assess the individual and 
discuss the scores to come to a consensus score. Further analysis of this scale (Mueser, Curran & 
McHugo, 1997) revealed a factor structure for the measure. These four factors are Thought 
Disturbance, Anergia, Affect, and Disorganization. For the purposes of this study, scores for 
each of the four factors were calculated for each participant and employed for analyses listed 
below. 
Cognitive Functioning. 
MATRICS Consensus Cognitive Battery (MCCB) (Nuechterlein et al., 2008).  The 
MCCB was created by a mandate of the National Institute of Mental Health’s Measurement and 
Treatment Research to Improve Cognition in Schizophrenia to standardize the measurement of 
cognitive functioning in schizophrenia. The tests selected to be included in the MCCB are as 
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follows: Trail Making Test, Part A; Brief Assessment of Cognition in Schizophrenia, symbol 
coding subtest; Hopkins Verbal Learning Test – Revised, immediate recall (three learning trials 
only); Wechsler Memory Scale, 3rd ed., spatial span subtest; Letter-Number Span test; 
Neuropsychological Assessment Battery, mazes subtest;  Brief Visuospatial Memory Test – 
Revised; Category Fluency test, animal naming; Mayer-Salovey-Caruso Emotional Intelligence 
Test, managing emotions branch; and Continuous Performance Test, Identical Pairs version. 
These tests were selected to assess the cognitive domains of speed of processing, verbal learning, 
working memory (verbal and nonverbal), reasoning and problem solving, visual learning, social 
cognition, and attention/vigilance (Nuechterlein et al., 2008).  August, Kiwanuka, McMahon, 
and Gold (2011) found the measures to be highly sensitive to the type and level of impairment 
typically observed in schizophrenia, MCCB composite scores are highly correlated with the 
WASI FSIQ, and the domain scores are generally moderately-highly correlated.  
Wechsler Abbreviated Scale of Intelligence (WASI). The Wechsler Abbreviated Scale of 
Intelligence is brief assessment of intelligence, taking 15-30 minutes to administer. The WASI 
meets the demands for fast accurate measurements of intelligence. The WASI is a general 
intelligence, or IQ test designed to assess specific and overall cognitive capabilities and is 
individually administered to children, adolescents, and adults (ages 6-89). It is a battery of four 
subtests: Vocabulary (31-item), Block Design (13-item), Similarities (24-item) and Matrix 
Reasoning (30-item). In addition to assessing general, or Full Scale, intelligence, the WASI is 
also designed to provide estimates of Verbal and Performance intelligence consistent with other 
Wechsler tests. Specifically, the four subtests comprise the full scale and yield the Full Scale IQ 
(FSIQ-4). The Vocabulary and Similarities subtests are combined to form the Verbal Scale and 
yield a Verbal IQ (VIQ) score, and the Block Design and Matrix Reasoning subtests form the 
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Performance Scale and yield a Performance IQ (PIQ) score. The WASI is estimated to have a 
reliability coefficient in the range of .93 - .98. The test-retest stability of the measure is estimated 
to be correlated at r = .92 for the four subtest FSIQ score. The validity of the measure was 
estimated by comparing the WASI to the Wechlser Adult Intelligence Scale-III. The two 
measures FSIQ were estimated to be correlated at r = .92. 
Mini Mental State Examination II (MMSE-II). The MMSE-II is an assessment 
designed to screen for cognitive impairments. The assessment has been shown to have high inter-
rater reliability, with intraclass correlations ranging from .94 to .99, with many tasks achieving 
100% agreement. The MMSE-II is known to have internal consistency estimates of Cronbach’s 
alphas ranging from .36 to .57 in normative samples and alphas ranging from .66 to .79 in 
samples of dementia patients. Test-retest stability is estimated to be from .79 to .98. In the 
current research, the MMSE was used to screen for dementia.  
Procedure  
 
 Each participant took part in a number of tasks and measures, including: a demographics 
questionnaire, a non-invasive measurement of MPAs, the Scheduled Clinical Interview for the 
Diagnosis of DSM-IV-TR Axis I Disorders (SCID-I), the Wechsler Abbreviated Scale of 
Intelligence (WASI), MATRICS Consensus Cognitive Battery (MCCB), Peters Delusion 
Inventory (PDI), and the Cardiff Anomalous Perceptions Scale (CAPS). Following the 
completion of the SCID, Symptom Severity was rated with the Scale for the Assessment of 
Negative Symptoms (SANS), the Scale for the Assessment of Positive symptoms (SAPS), and 
the Brief Psychotic Rating Scale (BPRS).  
Results 
Data Preparation 
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 The data were prepared for analysis by observing the individual measurements for each 
MPA, cognitive domain, and symptom domain. Three data points were removed due to obvious 
errors that appeared to occur during the MPA assessment. Some of the participants did not return 
for the second or third assessment sessions and others refused to allow the experimenter to 
measure some parts of their bodies. Because of this, the data is not missing completely at random 
and imputation of missing values would not be appropriate.  
MPAs Differences between “Healthy Controls” and Schizophrenia Group 
 The first goal of this study was to evaluate if there is a between-groups difference in the 
presence of MPAs within an ethnically diverse setting. For MPAs that were measured as 
continuous variables, independent samples t-test were run to examine differences between the 
schizophrenia and healthy control groups (see Table 3). For MPAs that were measured as 
dichotomous variables, chi-square tests were run (see Table 4). No significant differences 
between groups were found for either the continuous or dichotomous MPAs. A few of the tests 
of between groups differences were approaching significance (p < .08), but due to the number of 
test performed on the datum a correction of the alpha level needed to be performed to avoid a 
Type I error. Using the Bonferroni method of correction for 27 tests, the individual test must 
reach a p-value less than 0.0019. None of the tests performed reached p < 0.0019, indicating 
there are no differences between the groups in the presentation of MPAs. There were also few 
significant correlations among the individual MPAs in relation to other MPAs (Table 57). 
MPAs and Cognition 
 Significant differences are present between the Healthy Control and the Schizophrenia 
group for all domains of the MCCB and WASI. Individuals in the Schizophrenia group scored 
significantly lower on all of the domains compared to healthy controls (Table 55). Based on the 
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norms of the MCCB and WASI, the healthy controls scored in the “normal” range for both of the 
assessments. 
Hair Whorls. Since hair whorls were measured as a dichotomous presence/absence 
variable, differences in cognitive functioning were examined between people with and without 
hair whorls with independent samples t-tests. There were no significant differences on the 
cognitive variables for hair whorl direction or count on the cognitive variables (see Table 6-7). 
There were no significant differences in whorl presence/absence on the MCCB. Individuals 
without a hair whorl (M = 80.33) had significantly lower scores, t (56) = 2.43, p = 0.018, d = -
1.04) on the VCI domain of the WASI compared to individuals with a whorl present (M = 95.42; 
see Table 5). A one-way ANOVA showed a significant difference, F (2,39) = 3.40, p = 0.04, d  = 
1.85, between individuals with hair whorls on the midline, left of the midline, and right of the 
midline. A post hoc Tukey’s HSD test indicated that the mean score for individuals with a hair 
whorl on the midline (M = 51.45, SD = 4.00) was significantly higher than individuals with a 
whorl to the right of midline (M = 43.94, SD = 4.12) on the RPS domain. However, individuals 
with a hair whorl to the left of midline did not significantly differ from the other two groups. A 
significant difference was also present between these groups on the PRI domain of the WASI, F 
(2,43) = 6.78, p = 0.002, d = 3.56. A follow up Tukey’s HSD test revealed individuals with a 
whorl present to the left of midline scored (M = 84.00, SD = 6.22) significantly lower compared 
to individuals with a whorl on the midline (M = 107.5, SD = 6.96). These post hoc test also 
revealed that individuals with a whorl to the right of center (M = 95.88, SD = 7.29) and 
individuals with a whorl on the midline was approaching significance, p = 0.06 (see Table 8). 
Tests conducted within the schizophrenia group only found a significant difference F (2,20) = 
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3.40, p = 0.04, d = 2.94, between individual with a hair whorl left-of-center (M = 49.50, SD = 
4.31) and those with a whorl right-of-center (M = 35.49, SD = 5.18).  
 Head Circumference. Since head circumference was measured as a continuous variable, 
Pearson correlations were examined between head circumference and the cognitive variables. 
There were no significant correlations between head circumference and any of the cognitive 
variables (see table 9).  
 Facial Proportions. Facial proportions were measured on a continuous scale and 
compared to scores on the cognitive domains using correlation techniques. There was a 
significant positive correlation between the facial proportion and the Verbal Learning Domain of 
the MCCB, r = 0.27, p = 0.03, d = 0.56.  A significant negative correlation, r = 0.44, p = 0.008, d 
= 0.98, is also present within the schizophrenia group and the Social Cognition domain of the 
MCCB. No significant relations between facial proportions and the other MCCB domains and 
the WASI were present (see Table 10). In the schizophrenia group, a significant negative 
correlation, r = 0.41, p = 0.009, d = 0.89, is present, indicating as the middle of the face becomes 
proportionally smaller to the bottom of the face scores on the WASI Full Scale IQ became 
smaller. 
 Ears. No participants presented with gross malformation of the ears, therefore no t-tests 
could be conducted on this MPA. No Significant relations were found between ear symmetry, 
earlobe attachment/detachment, or ear protrusion to the cognitive variables (see Tables 11-14). 
Within the schizophrenia group, a significant negative correlation is present, r = .33, p = 0.041, d 
= 0.69. 
Palate. Palate shape was measured as a categorical variable (U-shaped palate, a steepled 
palate with a flattened apex, or a steepled palate with a V-shaped apex) and evaluated with 
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ANOVA techniques. The presence of palatal ridges was measured in two ways, presence of 
ridges and the number of ridges present. T-tests were used to evaluate the differences in scores 
for the presence/absence of the ridges, while correlation techniques were used to evaluate the 
relation of ridge count. No significant relations were present between palatal shape, presences of 
ridges or palatal ridge count to the measures of cognition (see Tables 15-17). 
 Tongue. No significant relations were present between the presence/absence of tongue 
furrows or presence/absence of a bifid tongue on the cognition variables with independent 
samples t-tests (see Tables 18, 21). A T-test revealed a significant difference, t (23) = 2.08, p = 
0.049, d = 2.73, between individuals with tongue furrows on the midline (M = 34.14, SD = 2.38) 
and those with a furrow not on the midline (M = 46.50, SD = 5.95) on the Attention/Vigilance 
domain of the MCCB. A significant relation, t (27) = 2.07, p = 0.48, d = 2.75, also indicated that 
individuals with a furrow on the midline of the tongue scored lower (M = 43.08, SD = 2.45) 
compared to those with a furrow not on the midline (M = 56.75, SD = 6.59) on the Working 
Memory domain (see Table 19). A T-test revealed that individuals with tongue spots present 
scored significantly, t (62) = 3.17, p = 0.002, d = 4.32, higher on the Speed of Processing domain 
of the MCCB (M = 58.60, SD = 5.34) than individuals without tongue spots (M = 41.66, SD = 
1.49) (see Table 20). Within the schizophrenia group, a significant difference, t(38) = 4.203, p = 
0.0473, d = 2.82, is present between individuals with a bifid tongue (M = 15, SD = 2.39) and 
those without a bifid tongue (M = 10.11, SD = 0.53). A significant difference is also present in 
the schizophrenia group. Within this group, individual without a bifid tongue (M = 93.56, SD = 
2.25) scored significantly higher, t(38) = 4.61, p = 0.00004, d = 2.01 , on the VCI domain of the 
WASI compared to those with a bifid tongue (M = 82.16, SD = 7.70). 
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Eyes. No significant differences were found for any of the cognitive variables between 
groups with a present or absent epicanthal covering, and there were no significant correlations 
between hypertelorism and the cognitive variables (see Tables 22, 24) with independent samples 
t-tests. An ANOVA revealed a significant difference, F (3,63) = 2.93, p = 0.04, d = 2.72, 
between individuals without any strabismus (esotropia, exotropia, hypertropia) and those with 
some form of it on the Perceptual Reasoning Domain of the WASI. A post-hoc Tukey’s HSD 
revealed that individuals without strabismus (M = 98.89, SD = 12.57) scored significantly higher 
than individuals with esotropia (M = 65.00, SD = 12.38) on the Perceptual Reasoning domain of 
the WASI (see Table 23). A significant positive correlation, r = 0.34, p = 0.049, d = 0.72, is 
present within the schizophrenia group on the composite score of the MCCB. 
Hands. The sample acquired for this study did not have any individual present with a 
single transverse palmer crease, therefore no t-tests were conducted.  No significant correlations 
were present for the curvature of the fifth finger or middle/index finger ration and the cognitive 
variables (see Table 25-26) which were measured as continuous variables. In just the individuals 
with schizophrenia, a significant positive correlation, r = 0.37, p = 0.028, d = 0.79. 
Feet. No participants in this study presented with partial syndactyly of the second and 
third toes, measured as a dichotomous variable, therefore no t-tests with cognitive variables 
could be conducted. No significant correlations were present for the measure of partial 
syndactyly for differences in toe lengths, measured as a continuous variable, and the cognitive 
variables (see Tables 27-28). Several significant correlations were present between the size of the 
gap between the first and second toe and the domains of the MCCB. The size of the toe gap was 
found to be a significant predictor of the following domains; Working Memory, r = .45, p < 
0.001, d = 1.01, Verbal Learning, r = .34, p = 0.006, d = 0.72, Reasoning and Problem Solving, r 
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= .32, p = 0.009, d = 0.67, Social Cognition, r = .39, p = 0.002, d = 0.85, and the composite 
score, r = .51, p < 0.001, d = 1.18, for all the MCCB subtests. A significant correlation, r = 0.28, 
p = 0.02, d = 0.58, was also present on the Perceptual Reasoning Index of the WASI (see Table 
29). Within the schizophrenia group, significant positive correlations are present for the 
Composite Score, r = 0.53, p = 0.002, d = 1.25, Reasoning and Problem Solving, r = 0.34, p = 
0.03, d = 72, Working Memory, r = 0.35, p = 0.03, d = 0.75, and Speed of Processing, r = 0.49, p 
= 0.002, d = 1.12, domains of the MCCB. All the significant correlations were positive, 
indicating that as the gap in between the first and second two increases, the individuals scores on 
the domains also increased. 
The Bonferroni method of correction for the 275 tests in this section makes the required 
p-value for each test to be less than 0.00018. None of the tests in the above section meet this 
criterion and the significant results reported may be due to chance alone. 
MPAs and Symptom Severity 
 Significant differences are present between the Healthy Control group and the 
Schizophrenia group on the CAPS, PDI, and all domains of the BPRS. Individuals in the 
Schizophrenia group have higher scores on these scales indicating higher symptoms associated 
with schizophrenia (Table 56). 
 Hair Whorls. Since hair whorls were measured as a dichotomous presence/absence 
variable, differences in cognitive functioning were examined between people with and without 
hair whorls with independent samples t-tests. No significant results were present for hair whorl 
direction nor count on the symptoms rating variables of the BPRS. (see Tables 30, 32). A T-test 
revealed a significant difference in the presence/absence of hair whorls on the CAPS, t (50) = 
2.17, p = 0.03, d = 2.22, and the PDI, t (53) = 2.25, p = 0.03, d = 2.30. Individuals with a hair 
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whorl present (M = 5.77, SD = 3.34) scored significantly lower on the CAPS compared to 
individuals without a hair whorl (M = 13.00, SD = 3.17). On the PDI, individual with a whorl 
scored (M = 9.98, SD = 4.72) significantly lower than individuals without a hair whorl (M = 
20.60, SD = 4.50; see Table 31). ANOVA tests revealed significant differences between the 
position of the hair whorl on the Thought Disturbance, F(2,40) = 5.57, p = 0.007, d =2.42, 
Affect, F(2,40) = 5.50, p = 0.008, d = 3.24, and Disorganization, F(2,40) = 3.88, p = 0.03, d = 
2.66, domains of the BPRS. The post-hoc Tukey’s HSD revealed that individuals with a whorl 
on the midline (M = 7.21, SD = 2.15) were rated significantly lower than individuals with a 
whorl to the right of midline (M = 12.62, SD = 2.32) on the Thought Disturbance domain. On the 
Affect domain, individuals with a whorl on the midline (M = 7.54, SD = 1.50) were rated 
significantly lower than individuals with a whorl right of midline (M = 10.92, SD = 1.63). On the 
Disorganization domain, a significant difference was found between individuals with a whorl on 
the left of midline (M = 6.17, SD = 0.77) and individuals with a whorl placed on the midline (M 
= 4.00, SD = 0.86) (see Table 33). Within the schizophrenia group, individuals with a hair whorl 
to the right-of-center (M = 15.67, SD = 2.26) were rated significantly, F(2,22) = 5.25, p = 0.014, 
d = 2.46, than individuals with a hair whorl on the midline (M = 10.18, SD = 2.19)  and left-of-
center (M = 10.20, SD = 1.82). 
Head Circumference. Head circumference was measured on a continuous scale and their 
relation to symptom domains of the BPRS was evaluated with correlation techniques. There were 
no significant correlations for head circumference and the symptom variables (see Table 34). 
 Facial Proportions. Facial proportions were assessed using a continuous scale and their 
relation to the symptom domains of the BPRS was evaluated with correlations techniques. No 
significant correlations were found between facial proportion and the symptom variables for the 
Running head: Minor Physical Anomalies and Specific Symptoms of Schizophrenia 36 
full sample (see Table 35). A significant negative correlation, r = -0.34, p = 0.037, d = 0.72, is 
present between facial proportions and the Affect domain of the BPRS. 
Ears. No participants presented with grossly malformed ears, therefore no test could be 
conducted. No significant differences were for present attachment/detachment of the ears. No 
significant correlations were present for ear symmetry, nor ear protrusion and the symptoms 
domains of the BPRS (see Tables 36-39). Tests within the schizophrenia group, revealed 
significant differences for ear protrusion and ear symmetry. A significant correlation, r = 0.41, p 
= 0.01, d = 0.89, reveals as the protrusion of the left ear increases the ratings on the Anergia 
domain of the BPRS also increased. The symmetry between the left and right ear height was also 
significantly positively correlated, r = 0.43, p = 0.009, d = 0.95, with scores on the CAPS. 
 Palate. No significant differences were present for palatal shape (U-shaped palate, a 
steepled palate with a flattened apex, or a steepled palate with a V-shaped apex), nor the 
presence/absence of palatal ridges.  Correlations of the count of palatal ridges and the symptom 
domains also showed no significant relations (see Tables 40-42). 
Tongue. T-tests were not significant for the presence/absence of tongue furrows, nor the 
placement of the tongue furrow (midline, non-midline), nor the presence/absence of tongue spots 
and the symptoms rating domains (see Tables 43-46). Within the schizophrenia group, a 
significant difference, t(38) = 4.203, p = 0.0473, d = 2.82, is present between individuals with a 
bifid tongue (M = 15.00, SD = 2.39) and those without a bifid tongue (M = 10.11, SD = 0.53) on 
the Affect domain of the BPRS. Individuals in the schizophrenia group with a bifid tongue (M = 
28.00, SD = 6.52) also scored significantly, t(33) = 2.65, p = 0.12, d = 3.69, higher on the CAPS 
than individuals without a bifid tongue (M = 10.74, SD = 1.10). 
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Eyes. No significant relations are present for strabismus nor hypertelorism and the 
symptom rating domains (see Tables 48-49). An ANOVA revealed a significant difference, F 
(2,61) = 3.69, p = 0.03, d = 1.11, in individuals manifestation of epicanthal covering of the 
crancula on the Affect domain of the BPRS. The post hoc Tukey’s HSD showed individuals with 
no coverage of the crancula (M = 8.17, SD = 2.37) were rated significantly lower than 
individuals with partial coverage (M = 10.86, SD  = 2.48) on the Affect domain. No other 
between group differences were significant (see Table 47). 
Hands. No participants presented with a single transverse palmer crease, therefore no 
significance tests were conducted. No significant correlations are present for the relation of the 
curvature of the fifth finger and the symptom variables (see Table 50). A significant positive 
correlation, r = 0.32, p = 0.009, d = 0.67, is present for the middle/index finger ration and the 
Disorganization domain of the BPRS (see Table 51). 
Feet. No participants in the study had visible partial syndactyly of the second and third 
toes, therefore no test could be conducted. No significant correlations are present between 
syndactyly measured with toe length or the gap between the first and second toe and the 
symptom rating domains (see Tables 52-54). 
The Bonferroni method of correction for the 150 tests in this section makes the required 
p-value for each test to be less than 0.0003. None of the tests in the above section meet this 
criterion and the significant results reported may be due to chance alone. 
Discussion 
 The first research question for this study was if differences there were differences in 
presence and severity of MPAs between people with schizophrenia and health controls. The 
study found no significant differences between groups in MPAs. This null result is not consistent 
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with previous research that found a difference in the presence of MPAs between the groups. 
Some of the published literature (e.g., Gualtieri, Adamz, Shen, & Loiselle, 1982; Schiffman, et. 
al., 2002; Trixler, Tényi, Csábi, & Szabó, 2001) reported significantly higher numbers of MPAs 
present in individuals with schizophrenia compared to “healthy controls” and people with other 
disorders such as Bipolar I (e.g., Akabealiev, Sivkov, & Matarkov, 2014; Green, Satz, & 
Christenson, 2004). Moreover, a meta-analysis found that the average effect size of the different 
in MPAs between groups was very large (Cohen’s d = 0.95; Xu, Chan, & Comptom, 2011). 
Thus, the results of the current research are very different from many previous studies.  
One potential reason for the difference between the results of the current study and 
previous research may be due to differences in the measurement of MPAs. Much of the previous 
research focused on dichotomous (present/not present) identification of the MPAs and this 
research used quantitative measurements and qualitative measurements with more than two 
levels when possible. Most of the previous research that relied on dichotomous ratings of the 
MPAs likely needed to show a gross malformation of the area to be identified as having the 
MPA present. The current study was designed to represent the variation of MPAs as a spectrum. 
One example of this difference is the measurement of toe gap. The current study used a precise 
measuring device placed between the first and second toes to evaluate the actual space between 
the toes on a continuous scale, while the previous research used a visual inspection to make a 
decision if a wide toe gap was present or not on dichotomous scale. These differences in 
measurement type may have led the results of the current study to be null due to the variation in 
the healthy control group and the schizophrenia group not having a significant difference in the 
mean toe gap size. The previous research, using a dichotomous measurement, may have found 
more individuals with extreme toe gaps in the schizophrenia group that did not account for the 
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full variation in toe gaps. This may have lead previous researchers to find a significant difference 
between the groups because there were only identifying extreme values. Another consideration 
for this study finding null results is almost all of the previous research evaluated the group 
differences based on a total count of MPAs present. The total number of MPAs was counted for 
individuals in each group and a comparison between the groups was made. The differences in the 
number of MPAs does not account for which MPAs were counted and how extreme the MPAs 
may have been presented.  
 The second goal of this study was to evaluate the relation of individual MPAs and scores 
on tests of cognition and symptom ratings. Although none of these relations were significant at 
Bonferroni-adjusted p-values, some findings were significant at the traditional alpha level of 0.05 
and are worth exploring. For example, the relation of the size of the toe gap between the first and 
second toes was positively correlated with several measures of cognition including Working 
Memory, Verbal Learning, Reasoning and Problem Solving, Social Cognition, and the MCCB 
Composite Score. This finding is different from the other MPA results in this study because 
many did not significantly predict cognition on any of the domains while some were predictive 
of a single domain. These results are opposite of the hypothesized results. Since having a large 
toe gap is considered an MPA on the Waldrop-Havlerson scale, it was expected that as the toe 
gap increased the scores on the measures of cognition would decrease. None of the previous 
research examining the relation of MPAs and cognition reported findings similar to this. The 
majority of previous research did not look at specific MPAs, rather they used a count of the total 
MPAs present. Based on the use of a novel MPA assessment and more specific measurement 
criteria, it is not possible to compare the results from this study with the results of previous 
research using a total MPA count.  
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 Another interesting result was the relation of hair whorl placement and the symptom 
ratings. Hair whorl placement was significantly related to three of the four domains of the BPRS 
(Thought Disorder, Affect, and Disorganization) without correcting the p-value for the number 
of tests conducted. The results as a whole indicate that having a hair whorl that is not placed on 
the midline was related to higher scores on the BPRS domains, meaning that non-midline hair 
whorl placement indicates higher levels of dysfunction as rated by the BPRS. These results are 
novel to this study and have not been reported by previous research which found significant 
relations of total MPAs and scores on the Family Picture I and II of the Wechsler Memory Test 
III (Mittal & Walker, 2011) and the Peabody Picture Vocabulary Test (Rosenberg & Weller, 
1973). The results of this study indicate a possible developmental difference among individuals 
that were rated higher on the BPRS domains and those rated lower that is physically represented 
by a non-midline hair whorl. The results from this study revealed some trends of differences in 
cognition and symptom ratings associated with specific MPAs, it is unlikely that the 
presence/severity of the MPAs could actually be translated into diagnostic criteria for 
schizophrenia. 
  Another goal of this study was to evaluate the relation of MPAs grouped by location 
(head, feet, midline, lateral) to the cognitive domains and the symptom ratings. Due to the 
number of non-significant tests and the missing data in the measurement of MPAs, this analysis 
was not possible. Most statistical packages use list-wise deletion when analyzing statistical 
models. This method removes all of the data for the individual if a single datum is missing for 
that individual. Using this method to analyze the data from the current study would result in a 
greatly reduced sample size making possible differences between groups harder to detect and 
reducing the generalizability of the findings to the population. Pair-wise deletion was also not a 
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good option for study. This method only removes the missing data between individual variables 
allowing for more of the data to be used in the analysis. Pair-wise deletion is considered to have 
unbiased estimates for the regression model when the data is assumed to be missing completely 
at random (Peugh & Enders, 2004). An analysis of missingness revealed in a non-significant 
result, indicating that the data is missing completely at random. Also, the number of non-
significant results indicate a very small amount of variance of the scores being explained. By 
adding multiple predictive variables, the total variance explained by the regression model will 
increase, but it is highly unlikely that the higher order models will be significant predictors of 
symptom ratings or cognition. Although these analyses could not be conducted, stepwise 
regressions with multiple MPAs predicting the domains of the cognitive score and symptoms 
ratings were completed. These analyses did not find any models that were significantly better at 
predicting the scores and ratings than individual MPAs. 
 In addition to the limitations of conducting the analysis of the MPA groups, the study in 
general has other limitations to consider. One of these limitations is the sample size acquired for 
this study. Much of the previous research has had sample sized that are similar to sample of this 
study, while other have utilized samples of 120 or more participants. The small sample size 
makes true differences between the healthy controls and the schizophrenia groups more difficult 
to detect. A larger sample may have made the differences between the groups clearer and the 
results that are trending toward a significant p-value may have become significant. For example, 
the correlation between facial proportions and the Verbal Learning domain of the MCCB 
achieved an actual power of 0.56 with a sample size of 61. Using the achieved r from the tested 
model to calculate the needed sample size to find and effect if one exists, a sample of 172 
participants is needed. The a priori tests used to determine the required sample for this study 
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using an effect size of d = 0.98 (Xu, Chan, & Comptom, 2011) calculated a need for 115 
participants to find significant results. Due to limitations in resources available, it was not 
possible to include this large of a sample in the current study.  
 In addition to a relatively small sample size, the finding of the current research may have 
differed from previous research due to the use of hand tools to measure MPAs. Although this led 
to more precise measure of MPAs, it is different from the methods used in previous research and 
may have led to different results. Also, none of the participants had their MPAs measured by 
more than one researcher, therefore no ICC can be calculated to determine if all of the 
researchers were measuring the MPAs reliably. Another way to improve the measurement of 
MPAs in future studies could be to use computer assisted measurement. This could be done by 
taking photos of the MPAs and using computer software (like face recognition) to measure the 
areas of interest to improve accuracy and quality of the measurements. To the best of our 
knowledge, no computer assisted analysis has been conducted in the previous research. 
 In addition to a lack of reliability data, another limitation of the current research is that no 
questions were asked about post-natal injuries that may have occurred to the individual that 
could affect the presentation of the MPA itself. Although these questions are not typically asked 
in MPA research, they could help to determine if the MPAs where present since birth and thus 
reflect abnormalities during in utero development or if they were due to post birth accidents or 
surgery.  One of the participants in our study reported that he was born with an extra toe on each 
foot but the toes were removed when he was a child and he did not have any manifest MPAs in 
this area at the time of the assessment. Relatedly, it is possible that some of the MPAs we did 
observe for a result of surgery or accidents, which we would not expect to be related to 
schizophrenia, symptoms, or cognitive functioning.  
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 Another potential reason why our results differed from previous studies could be that our 
study included a wide range of ethnicities. However, no published articles could be found to 
support developmental differences during the 9-12-week period of in utero gestation across 
ethnicities. The original MPA scale was developed by Waldrop & Halverson using a sample of 
Caucasian children, and since its development the MPAs have been observed in other ethnicities, 
including Asians (Lin et al., 2012). Therefore, ethnic differences do not appear to have a direct 
effect on the presentation of MPAs. Based on previous research and lack of evidence in 
developmental differences, ethnic identity was not considered to test between-group differences 
in the presentation of MPAs.   
 The null results from this study may be due to the type of measurements used and the 
way MPAs are manifest in individuals. There is currently a debate as to whether schizophrenia 
and the associated symptoms are on a continuous scale or if they follow a dichotomous 
taxonomy. Some researchers have found evidence that the symptoms of schizophrenia may be on 
a continuous scale, even in the general population (Van Os, Hanssen, Bijl, & Ravelli, 2000), 
while others suggest that schizophrenia is taxon that is either present or not present 
(Lenzenweger, 1994). This study aimed to elaborate on the way MPAs have been measured and 
provide a dimensional look at the expression of them. This method may not work with MPAs as 
their presentation may not be a dimensional construct. The presentation of MPAs may require 
developmental processes to be interrupted to a certain extent that causes the differences in 
development to manifest as an MPA itself. By measuring the MPAs on a dimensional scale, the 
ability to detect differences between the groups may have been lost due to the normal variation in 
the associated regions. By measuring the MPAs on continuous scale, a more accurate relation 
between MPAs and the symptoms and cognition in schizophrenia may be examined.  
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 Although the results of the current research were not consistent with many studies that 
have found a relation between MPAs and schizophrenia, its symptoms, and cognitive deficits, it 
is important to note that the results of these studies have also been mixed. For example, some 
studies have not found these significant relations (Alexander, Mukherjee, Richter, & Kaufmann, 
1994; Hope, Bates, & Gow, 2012; Rosenberg, & Weller, 1973). Another important consideration 
is that null results are not regularly published, making it difficult to determine if MPAs are truly 
related to cognition and symptoms of schizophrenia. This research did not replicate the results of 
some previous research, but new possible associations were found (toe gap and hair whorl 
location).   
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List of Tables 
Table 1 
Findings from Research Measuring Minor Physical Anomalies, Symptoms, and Cognitive 
Deficits 
Article Findings 
MPAs and symptoms with significant results 
Akabealiev, Sivkov, & Matarkov, 2014 Lowest MPA scores in “healthy control”, 
intermediate in bipolar I disorder, and highest in 
schizophrenia 
Compton et al., 2007 Significant positive correlations between MPAs 
of the mouth and Positive Symptoms; MPAs of 
the feet and positive symptoms. Significant 
negative correlations of MPAs of the mouth and 
Negative Symptoms; MPAs of the ears and 
general psychopathology symptoms. 
Griffiths et al., 1998 Higher total MPAs associated with individuals 
diagnosed with schizophrenia with no family 
history.   
Green, Gaier, Ganzell & Kharabi, 1989 People with schizophrenia have significantly 
more MPAs than “normal controls”. People with 
schizophrenia were found to have a high 
incidence of abnormalities of the mouth and head 
size. 
Green, Satz, & Christenson, 2004 Significantly more MPAs found on people with 
schizophrenia compared to “normal controls” 
and people with bipolar disorder. 
Gualtieri, Adams, Shen, & Loiselle, 1982 People with schizophrenia have significantly 
higher scores of total MPAs compared to 
“normal” adults. 
Lloyd et al., 2008 Overall facial symmetry, symmetry of the orbital 
landmarks and lowered Frankfurt horizontals 
significantly differentiated first-episode 
psychosis participants from controls. Affective 
psychosis participants had lowered eye fissures 
compared to controls. 
O’Callaghan et al, 1995 Significant relationship between MPAs and 
SANS (r = .316) and National Adult Reading 
Test (r =-.367*) 
Schiffman, J., Ekstrom, M., LaBrie, J., 
Schulsinger, F., Sorensen, H., 
Mednick, S., (2002) 
MPAs significantly associated with 
schizophrenia spectrum disorder relative to no 
mental illness. No significant differences in 
MPA scores between schizophrenia and other 
psychopathology. High risk individuals more 
likely to have MPAs. 
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Trixler, M., Tényi, T., Csábi, G., Szabó, R., 
(2001) 
Significantly more total number of MPAs in 
individuals with schizophrenia compared to 
individuals with bipolar disorder and control 
group. 
 
MPAs and symptoms with non-significant results 
Aksoy-Poyraz, 2011 No significant associations between MPAs and 
total SANS scores, SAPS scores, or disorganized 
dimensions. 
Lohr, & Flynn, 1993 No significant difference between people with 
schizophrenia and mood disorder patients. 
McGrath et al., 2002 No significant differences were found between 
individuals with non-affective psychosis and 
affective psychosis in total number of MPAs, 
craniofacial size factor, craniofacial shape factor, 
or width/length ratio. 
  
MPAs and cognitive abilities with significant results 
Ismail, Cantor-Graae, & McNeil, 2000 Significant difference between patients with 
High and Low MPA scores on Word Pairs 2 
Mittal & Walker, 2011 Significant differences between individuals with 
high and low MPA scores on the Wechsler 
Memory Scale III subtest Family Picture I and II. 
Those with higher MPA scores scored lower on 
the subtest. 
Rosenberg, J.B., & Weller, G.m., 1973 No significant relationship between MPA scores 
and performance IQ and personality factors. 
Significant negative correlation between MPA 
scores and the Peabody Picture Vocabulary Test. 
Study conducted with sample of 6-7 year-olds. 
 
MPAs and cognitive abilities with non-significant results 
Alexander, Mukherjee, Richter, & 
Kaufmann, 1994 
Total weighted Waldrop scores significantly 
positively correlated with third ventricle width 
and negatively correlated with tardive 
dyskinesia. No significant difference between 
individuals diagnosed with schizophrenia with 
family history and those with no family history. 
Age of onset, duration of illness, impairment in 
premorbid functioning, IQ, ventricle-brain ratio 
not significantly correlated with MPAs. 
Green, Bracha, Satz, & Christenson, 1994 No significant associations between MPAs and 
dermatoglyphics compared to information 
processing tasks (Degraded-stimulus continuous 
performance task, Span of apprehension, 
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Backward masking procedure, Pin Test, and 
Wisconsin Card Sorting Task). 
Hope, Bates, & Gow, 2012 No association between IQ and curvature of the 
fifth digit. 
O'Reilly, Lane, Cernovsky, & 
O’Callaghan, 2001 
No significant correlations between total MPAs 
scores and Neurological Evaluation Scale, nor 
Handedness. 
Rosenberg, J.B., & Weller, G.m., 1973 No significant relationship between MPA scores 
and performance IQ and personality factors. 
Significant negative correlation between MPA 
scores and the Peabody Picture Vocabulary Test. 
Study conducted with sample of 6-7 year-olds. 
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Table 2 
Demographic Information  
 Healthy Controls Patients 
   
Age Mean Sd Mean Sd 
 42.56 14.05 49.32 10.34 
Gender # of 
Participants 
# of 
Participants 
  
Male 16 25 
Female 15 22 
    
Ethnicity   
Caucasian 16 13 
Mixed 7 7 
Japanese 2 4 
Chinese 1 2 
 
Filipino 1 4 
Hawaiian 1 9 
Black 0 4 
Pacific 
Islander 
0 1 
Other 4 3 
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Table 3 
T-tests of Group Differences for Individual MPAs 
 Healthy 
Controls Patient 
   
MPA Mean SD Mean SD Df T P 
Head 
Circumference 
(cm) 
57.37 6.68 56.35 4.59 63 -0.73 0.47 
Facial 
Proportions 
0.98 0.19 0.97 0.15 69 -0.18 0.86 
Ear Symmetry 
(mm) 
2.11 2.30 1.67 1.26 71 -1.05 0.29 
Ear Protrusion:        
Left 13.35 4.68 15.12 3.77 69 1.75 0.08 
Right 13.05 4.47 14.58 3.27 69 1.67 0.10 
Palatal Ridge 
Count 
2.06 1.25 2.19 1.05 31 0.32 0.75 
Hypertelorism 30.26 4.72 32.04 4.35 70 1.65 0.10 
5th finger 
curvature 
78.38 30.71 80.75 27.52 68 0.34 0.74 
Index/Middle 
Finger Ratio 
0.88 0.05 0.89 0.15 71 0.36 0.72 
Syndactyly of 
Toes: 
       
2nd toe length 
differences 
3.69 4.69 4.53 3.11 71 0.92 0.36 
3rd toe length 
differences 
-3.57 2.70 -3.07 3.71 71 0.62 0.53 
Gap between 
1st and 2nd toes 
8.78 4.35 8.84 3.24 70 0.07 0.94 
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Table 4 
T-tests of Group Differences for Individual 
MPAs 
MPA Χ2 n df p 
Hair Whorls:      
Presence 3.48 61 1 0.06 
Count 0.39 45 1 0.53 
Direction 1.56 55 1 0.21 
Position 2.44 49 2 0.29 
Adherent 
Earlobes 
1.63 74 1 0.20 
Palatal Shape 5.68 73 2 0.06 
Palatal Ridge 
Presence 
1.62 71 1 0.20 
Tongue Furrows:     
Presence 0.22 74 1 0.64 
Placement 0.49 36 1 0.48 
Tongue Spots 0.85 73 1 0.36 
Bifid Tongue 0.72 74 1 0.39 
Epicanthal 
Covering 
1.84 73 2 0.39 
Strabismus§ 2.93 71 3 0.40 
Palmer Crease 0.00 74 1 1.00 
Toe Syndactyly 1.95 74 1 0.16 
§ Esotropia, Exotropia, and Hypertropia are 
only present in the Patient group 
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Table 5 
Relation of Hair Whorl Presence and the MCCB 
 Not Present Present    
Subtests Mean SD Mean SD df t p 
TMT 40.83 4.66 44.31 4.94 52 0.71 0.48 
BACS 40.33 5.33 44.98 5.65 52 0.82 0.42 
HVLT 35.00 4.12 40.81 4.37 52 1.33 0.19 
WMS 43.67 4.82 51.85 5.11 52 1.60 0.12 
LNS 41.67 5.12 41.50 5.43 52 -0.03 0.98 
Mazes 41.67 3.82 48.12 4.05 52 1.59 0.12 
BVMT 37.50 5.02 43.81 5.33 52 1.19 0.24 
Fluency 40.50 5.12 47.71 5.44 52 1.33 0.19 
MSCEIT 36.50 5.69 38.51 6.05 51 0.33 0.74 
CPT 36.67 4.39 39.30 4.68 47 0.56 0.58 
Domains        
SoP 37.50 5.20 44.21 5.52 52 1.22 0.23 
AV 36.67 4.39 39.30 4.68 47 0.56 0.58 
WM 41.17 5.24 45.91 5.56 52 0.86 0.40 
VrblLrng 35.00 4.12 40.81 4.37 52 1.33 0.19 
VisLrng 37.50 5.02 43.81 5.33 52 1.19 0.24 
RPS 41.67 3.82 48.12 4.05 52 1.59 0.12 
SC 36.50 5.69 38.51 6.05 51 0.33 0.74 
Comp 30.33 5.15 38.79 5.50 46 1.54 0.13 
Wasi 
Domains 
       
VCI 80.33 5.89 95.42 6.22 56 2.43 0.02* 
PRI 87.00 6.81 100.07 7.19 56 1.82 0.07 
Comp 82.00 9.34 91.87 9.86 56 1.00 0.32 
*p<.05        
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Table 6 
Relation of Hair Whorl Direction and the MCCB 
 
Clockwise 
Counter-
Clockwise 
   
Subtests Mean SD Mean SD df t p 
TMT 44.42 1.67 43.40 5.17 46 -0.20 0.84 
BACS 45.44 1.87 41.00 5.78 46 -0.77 0.45 
HVLT 41.79 1.57 32.40 4.78 46 -1.96 0.06 
WMS 51.49 1.81 55.00 5.59 46 0.63 0.53 
LNS 42.02 1.88 37.00 5.82 46 -0.86 0.39 
Mazes 47.81 1.36 49.60 4.21 46 0.66 0.51 
BVMT 44.42 1.87 37.60 5.80 46 -1.00 0.32 
Fluency 48.19 1.97 43.60 6.11 46 -0.75 0.46 
MSCEIT 38.51 2.11 38.50 7.24 45 -0.00 0.99 
CPT 38.97 1.69 41.80 4.95 41 0.57 0.57 
Domains        
SoP 44.67 1.88 40.20 5.83 46 -0.77 0.45 
AV 38.97 1.69 41.80 4.95 41 0.57 0.57 
WM 46.00 1.92 45.20 5.94 46 -0.14 0.89 
VrblLrng 41.79 1.57 32.40 4.78 46 -1.96 0.06 
VisLrng 44.42 1.87 37.60 5.80 46 -1.00 0.32 
RPS 47.81 1.36 49.60 4.21 46 0.66 0.51 
SC 38.51 2.11 38.50 7.24 45 -0.00 0.99 
Comp 38.82 1.91 38.50 6.18 40 -0.05 0.96 
Wasi 
Domains 
       
VCI 96.64 2.07 84.00 6.69 50 -1.89 0.06 
PRI 100.53 2.39 95.80 7.71 50 -0.61 0.54 
Comp 92.29 3.45 87.80 11.12 50 -0.40 0.69 
*p<.05        
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Table 7 
Relation of Hair Whorl Count and the MCCB 
BPRS One Whorl Two Whorls    
Subtests Mean SD Mean SD df t p 
TMT 45.63 1.68 49.00 10.49 37 0.32 0.75 
BACS 46.68 1.87 50.00 11.70 37 0.37 0.71 
HVLT 41.32 1.76 54.00 11.01 37 1.15 0.26 
WMS 53.03 2.23 35.00 12.63 37 1.43 0.16 
LNS 42.40 2.01 50.00 12.55 37 0.61 0.55 
Mazes 49.55 1.39 45.00 8.68 37 0.53 0.60 
BVMT 44.47 1.95 55.00 12.18 37 0.86 0.39 
Fluency 47.40 2.02 49.00 12.63 37 0.13 0.90 
MSCEIT 39.38 2.12 32.00 13.08 36 0.56 0.58 
CPT 38.86 1.69 51.00 10.12 34 1.20 0.24 
Domains        
SoP 45.37 1.92 50.00 11.97 37 0.39 0.70 
AV 38.86 1.69 51.00 10.12 34 1.20 0.24 
WM 47.18 2.09 41.00 13.06 37 0.47 0.64 
VrblLrng 41.32 1.76 54.00 11.01 37 1.15 0.26 
VisLrng 44.47 1.95 55.00 12.18 37 0.86 0.39 
RPS 49.55 1.39 45.00 8.68 37 0.53 0.60 
SC 39.38 2.12 32.00 13.08 36 0.56 0.58 
Comp 39.59 1.93 45.00 11.39 33 0.48 0.64 
Wasi 
Domains 
       
VCI 96.03 2.28 111.50 10.47 40 1.48 0.15 
PRI 100.60 2.55 101.50 11.69 40 0.08 0.94 
Comp 93.48 3.47 108.00 15.91 40 0.91 0.37 
*p<.05        
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Table 8 
Relation of the Whorl Position and the Cognitive Variables 
 Whorl Positon 
Left 
Whorl Position 
Midline 
Whorl Position 
Right 
   
Subtests Mean SD Mean SD Mean SD df F p 
TMT 39.67 3.87 49.45 4.41 38.06 4.54 2,39 7.05   0.00* 
BACS 42.33 4.45 47.70 5.08 39.13 5.22 2,39 2.80 0.07 
HVLT 37.50 4.39 40.95 5.00 42.06 5.15 2,39 0.39 0.68 
WMS 53.50 4.97 53.10 5.67 49.31 5.83 2,39 0.50 0.61 
LNS 37.67 5.18 41.55 5.90 40.13 6.07 2,39 0.23 0.80 
Mazes 47.83 3.52 51.45 4.00 43.94 4.12 2,39 3.40    0.04* 
BVMT 49.17 5.16 42.70 5.88 41.19 6.04 2,39 0.89 0.42 
Fluency 43.00 5.17 45.25 5.90 51.63 6.07 2,39 1.54 0.23 
MSCEIT 35.33 6.05 40.58 6.94 37.50 7.10 2,38 0.36 0.70 
CPT 43.40 4.17 38.95 4.69 38.54 4.91 2,34 0.54 0.59 
Domains          
SoP 39.00 4.64 46.55 5.29 40.56 5.45 2, 39 1.71 0.19 
AV 43.00 4.17 38.95 4.69 38.54 4.91 2,34 0.54 0.59 
WM 44.67 5.33 42.58 6.07 43.44 6.24 2,39 0.29 0.75 
VrblLrng 37.50 4.39 40.95 5.00 42.06 5.15 2, 39 0.39 0.68 
VisLrng 49.17 5.16 42.70 5.88 41.19 6.04 2,39 0.89 0.42 
RPS 47.83 3.52 51.45 4.00 43.94 4.12 2,39 3.40    0.04* 
SC 35.33 6.05 40.58 6.94 37.50 7.10 2,38 0.36 0.70 
Comp 38.20 5.30 40.17 5.99 35.62 6.24 2,33 0.56 0.58 
Wasi 
Domains 
         
VCI 92.83 5.90 94.12 6.57 96.27 6.98 2,43 0.16 0.85 
PRI 84.00 6.22 107.50 6.96 95.88 7.29 2,43 6.78 0.00* 
Comp 88.00 10.07 88.88 11.26 95.25 11.81 2,43 0.37 0.69 
*p<.05          
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Table 9 
Relation of Head Circumference 
and the Cognitive Variables 
Subtests df r p 
TMT 57 -0.01 0.94 
BACS 58 0.16 0.23 
HVLT 58 0.09 0.49 
WMS 58 0.16 0.22 
LNS 58 -0.11 0.39 
Mazes 58 -0.06 0.67 
BVMT 57 -0.06 0.65 
Fluency 58 -0.07 0.58 
MSCEIT 57 0.19 0.15 
CPT 52 -0.01 0.94 
Domains    
SoP 58 0.04 0.75 
AV 52 0.01 0.94 
WM 58 -0.16 0.23 
VrblLrng 58 0.09 0.49 
VisLrng 57 -0.06 0.65 
RPS 58 -0.06 0.67 
SC 57 0.19 0.15 
Comp 50 0.02 0.91 
Wasi 
Domains 
   
VCI 61 0.03 0.80 
PRI 62 0.00 0.98 
Comp 62 0.01 0.96 
*p<.05    
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Table 10 
Relation of Facial Proportion and 
the Cognitive Variables 
Subtests df r p 
TMT 60 0.19 0.12 
BACS 61 0.02 0.90 
HVLT 61 0.27 0.04* 
WMS 61 -0.01 0.93 
LNS 61 0.21 0.10 
Mazes 61 0.21 0.09 
BVMT 60 0.16 0.23 
Fluency 61 0.16 0.20 
MSCEIT 60 0.08 0.51 
CPT 54 -0.03 0.83 
Domains    
SoP 61 0.16 0.21 
AV 54 -0.03 0.83 
WM 61 0.10 0.42 
VrblLrng 61 0.27 0.04* 
VisLrng 60 0.16 0.23 
RPS 61 0.21 0.09 
SC 60 -0.08 0.51 
Comp 52 0.06 0.64 
Wasi 
Domains 
   
VCI 66 0.00 0.99 
PRI 67 0.03 0.82 
Comp 67 0.09 0.43 
*p<.05    
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Table 11 
Relation of Ear Lobe Attachment and the Cognitive Variables 
Cognitive 
Variables Attached 
Detached    
Subtests Mean SD Mean SD df t p 
TMT 42.83 2.19 44.05 2.77 62 0.44 0.66 
BACS 41.04 2.59 45.34 3.27 63 1.32 0.19 
HVLT 37.54 2.22 41.92 2.79 63 1.57 0.12 
WMS 50.50 2.60 49.85 3.27 63 -0.20 0.84 
LNS 38.92 2.49 42.85 3.14 63 1.26 0.21 
Mazes 48.91 1.93 46.42 2.43 63 -1.03 0.31 
BVMT 41.04 2.68 44.44 3.35 62 1.01 0.32 
Fluency 42.92 2.44 49.73 3.08 63 2.22 0.03* 
MSCEIT 32.91 3.11 40.44 3.88 62 1.94 0.06 
CPT 38.18 2.155 39.47 2.74 56 0.47 0.64 
Domains        
SoP 39.71 2.46 45.19 3.10 63 1.77 0.08 
AV 38.18 2.16 39.47 2.74 56 0.47 0.64 
WM 43.54 2.70 45.53 2.39 63 0.59 0.56 
VrblLrng 37.54 2.22 41.92 2.79 63 1.57 0.12 
VisLrng 41.04 2.68 44.44 3.35 62 1.01 0.32 
RPS 48.91 1.93 46.42 2.43 63 -1.03 0.31 
SC 32.91 3.11 40.44 3.88 62 1.94 0.06 
Comp 34.65 2.92 39.06 3.64 54 1.21 0.23 
Wasi 
Domains 
       
VCI 89.89 3.50 94.28 4.47 68 0.98 0.33 
PRI 99.65 3.62 96.39 4.58 68 0.71 0.48 
Comp 82.92 4.65 94.23 5.86 68 1.93 0.06 
*p<.05        
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Table 12 
Relation of Ear Symmetry and the 
Cognitive Variables 
Subtests df r p 
TMT 62 0.12 0.37 
BACS 63 0.04 0.76 
HVLT 63 0.04 0.76 
WMS 63 0.05 0.72 
LNS 63 0.02 0.90 
Mazes 63 0.11 0.40 
BVMT 62 0.06 0.62 
Fluency 63 0.02 0.87 
MSCEIT 62 0.00 0.99 
CPT 56 0.09 0.50 
Domains    
SoP 63 0.04 0.75 
AV 56 0.09 0.50 
WM 63 0.03 0.79 
VrblLrng 63 0.04 0.76 
VisLrng 62 0.06 0.62 
RPS 63 0.11 0.40 
SC 62 0.00 0.99 
Comp 54 0.01 0.95 
Wasi 
Domains 
   
VCI 68 0.09 0.44 
PRI 68 0.05 0.71 
Comp 68 0.09 0.43 
*p<.05    
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Table 13 
Relation of Left Ear Protrusion and 
the Cognitive Variables 
Subtests df r p 
TMT 60 0.14 0.27 
BACS 61 0.05 0.70 
HVLT 61 0.02 0.85 
WMS 61 0.02 0.90 
LNS 61 0.00 0.98 
Mazes 61 0.16 0.21 
BVMT 60 0.06 0.66 
Fluency 61 0.28 0.03* 
MSCEIT 60 0.05 0.69 
CPT 54 0.21 0.11 
Domains    
SoP 61 0.15 0.23 
AV 54 0.21 0.11 
WM 61 0.01 0.92 
VrblLrng 61 0.02 0.85 
VisLrng 60 0.06 0.66 
RPS 61 0.16 0.21 
SC 60 0.05 0.69 
Comp 52 0.10 0.47 
WASI 
Domains 
   
VCI 66 0.06 0.62 
PRI 66 0.12 0.32 
Comp 66 0.00 0.97 
*p<.05    
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Table 14 
Relation of Right Ear Protrusion and the 
Cognitive Variables 
Subtests df r p 
TMT 60 0.10 0.43 
BACS 61 0.02 0.88 
HVLT 61 0.06 0.66 
WMS 61 0.04 0.74 
LNS 61 0.00 0.98 
Mazes 61 0.13 0.32 
BVMT 60 0.06 0.63 
Fluency 61 0.27 0.04* 
MSCEIT 60 0.10 0.43 
CPT 54 0.16 0.25 
Domains    
SoP 61 0.15 0.24 
AV 54 0.16 0.25 
WM 61 0.06 0.66 
VrblLrng 61 0.06 0.66 
VisLrng 60 0.06 0.63 
RPS 61 0.13 0.32 
SC 60 0.10 0.43 
Comp 52 0.00 0.62 
Wasi 
Domains 
   
VCI 66 0.05 0.67 
PRI 66 0.12 0.31 
Comp 66 0.03 0.82 
*p<.05    
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Table 15 
Relation of Palatal Shape and the Cognitive Variables 
 Steepled w/ 
Flattened Apex  U-Shaped V-Shaped 
   
Subtests Mean SD Mean SD Mean SD df F p 
TMT 42.50 7.65 43.54 7.78 49.00 13.25 2,61 0.14 0.87 
BACS 45.00 7.48 43.51 7.66 51.00 14.96 2,62 0.18 0.84 
HVLT 39.33 6.37 40.13 6.52 54.00 12.73 2,62 0.79 0.46 
WMS 48.00 7.32 50.44 7.51 35.00 14.65 2,62 0.77 0.47 
LNS 33.67 7.09 41.64 7.27 50.00 14.19 2,62 0.85 0.43 
Mazes 42.33 5.52 47.62 5.65 45.00 11.03 2,62 0.47 0.63 
BVMT 42.67 7.49 43.05 7.68 55.00 14.99 2,61 0.42 0.66 
Fluency 58.33 7.08 46.64 7.26 49.00 14.17 2,62 1.31 0.28 
MSCEIT 48.00 8.82 37.32 9.04 32.00 17.65 2,61 0.77 0.47 
CPT 40.67 5.82 38.67 5.98 30.33 11.64 2,55 0.78 0.46 
Domains          
SoP 49.00 7.13 42.77 7.31 50.00 14.27 2,62 0.52 0.59 
AV 40.67 5.82 38.67 5.98 30.33 11.64 2,55 0.78 0.46 
WM 38.67 7.66 45.16 7.85 41.00 15.32 2,62 0.38 0.68 
VrblLrng 39.33 6.37 40.13 6.52 54.00 12.73 2,62 0.79 0.46 
VisLrng 42.67 7.49 43.05 7.68 55.00 14.99 2,61 0.42 0.66 
RPS 42.33 5.52 47.62 5.65 45.00 11.03 2,62 0.47 0.63 
SC 48.00 8.82 37.32 9.04 32.00 17.65 2,61 0.77 0.47 
Comp 38.33 7.68 37.29 7.89 45.00 15.36 2,53 0.17 0.84 
Wasi 
Domains 
         
VCI 87.00 10.54 92.13 10.79 109.50 16.67 2.66 0.37 0.37 
PRI 88.33 10.80 97.81 11.05 103.50 17.08 2,66 0.47 0.63 
Comp 86.67 13.03 90.83 13.33 108.00 20.59 2,66 0.62 0.54 
*p<.05          
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Table 16 
Relation of the Presence of Palatal Ridges and the Cognitive Variables 
MCCB Not Present Present    
Subtests Mean SD Mean SD df t p 
TMT 43.23 1.96 43.87 2.78 61 0.23 0.82 
BACS 41.78 2.67 46.26 3.23 62 1.39 0.17 
HVLT 39.00 1.95 42.16 2.78 62 1.14 0.26 
WMS 47.28 2.17 53.10 3.09 62 1.88 0.06 
LNS 40.94 2.21 42.13 3.16 62 0.38 0.71 
Mazes 49.13 1.66 45.32 2.37 62 -1.61 0.11 
BVMT 43.59 2.28 43.23 3.27 61 -0.11 0.91 
Fluency 46.13 2.17 49.16 3.09 62 0.98 0.33 
MSCEIT 36.94 2.75 39.45 3.88 61 0.65 0.52 
CPT 39.31 1.87 38.18 2.66 56 -0.43 0.67 
MCCB 
Domains 
       
SoP 41.72 2.18 45.19 3.11 62 1.12 0.27 
AV 39.31 1.87 38.18 2.66 56 0.43 0.67 
WM 42.84 2.33 47.00 3.32 62 1.25 0.22 
VrblLrng 39.00 1.95 42.16 2.78 62 1.14 0.26 
VisLrng 43.59 2.28 43.23 3.27 61 -0.11 0.91 
RPS 49.13 1.66 45.32 2.37 62 -1.61 0.11 
SC 36.94 2.75 39.45 3.88 61 0.65 0.52 
Comp 36.43 2.50 38.96 3.56 54 0.71 0.48 
WASI 
Domains 
       
VCI 89.03 3.17 96.09 4.45 65 1.59 0.12 
PRI 97.24 3.21 99.00 4.51 65 0.39 0.69 
Comp 88.61 3.93 94.24 5.52 65 1.02 0.31 
*p<.05        
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Table 17 
Relation of Palatal Ridge Count and the 
Cognitive Variables 
Subtests df r p 
TMT 29 0.13 0.47 
BACS 29 -0.07 0.70 
HVLT 29 0.19 0.30 
WMS 29 -0.05 0.79 
LNS 29 0.08 0.67 
Mazes 29 0.09 0.63 
BVMT 28 0.11 0.55 
Fluency 29 0.18 0.34 
MSCEIT 29 0.09 0.65 
CPT 25 0.02 0.91 
Domains    
SoP 29 0.12 0.52 
AV 25 0.02 0.91 
WM 29 0.02 0.92 
VrblLrng 29 0.19 0.30 
VisLrng 28 0.11 0.55 
RPS 29 0.09 0.63 
SC 29 0.09 0.65 
Comp 24 0.15 0.47 
Wasi 
Domains 
   
VCI 32 0.08 0.65 
PRI 32 0.15 0.39 
Comp 32 0.10 0.56 
*p<.05    
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Table 18 
Relation of the Presence of Tongue Furrows and the Cognitive Variables 
Cognitive 
Variables 
Not Present Present    
Subtests Mean SD Mean SD df t p 
TMT 43.47 1.85 43.73 2.69 62 0.10 0.92 
BACS 44.03 2.18 43.43 3.21 63 -0.19 0.85 
HVLT 41.43 1.86 39.00 2.74 63 -0.89 0.38 
WMS 50.14 2.15 50.03 3.17 63 -0.03 0.97 
LNS 40.60 2.08 42.33 3.07 63 0.57 0.57 
Mazes 47.00 1.61 47.73 2.37 63 0.31 0.76 
BVMT 42.29 2.22 42.27 3.24 62 0.61 0.54 
Fluency 48.06 2.10 46.23 3.08 63 -0.59 0.56 
MSCEIT 39.03 2.58 36.17 3.84 62 -0.74 0.46 
CPT 40.97 1.75 36.54 2.61 56 -1.70 0.09 
Domains        
SoP 43.63 2.09 42.63 3.07 63 -0.32 0.75 
AV 40.97 1.75 36.54 2.61 56 -1.70 0.09 
WM 44.40 2.24 45.27 3.29 63 0.26 0.79 
VrblLrng 41.43 1.86 39.00 2.74 63 -0.89 0.38 
VisLrng 42.29 2.22 42.27 3.24 62 0.61 0.54 
RPS 47.00 1.61 47.73 2.37 63 0.31 0.76 
SC 39.03 2.58 36.17 3.84 62 -0.74 0.46 
Comp 37.84 2.37 37.04 3.55 54 -0.23 0.82 
Wasi 
Domains 
       
VCI 91.47 3.05 93.76 4.37 68 0.52 0.60 
PRI 95.61 3.08 99.71 4.41 68 0.93 0.36 
Comp 93.14 4.02 86.84 5.77 68 1.11 0.27 
*p<.05        
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Table 19 
Relation of Tongue Furrow Placement and the Cognitive Variables 
 Midline Non-Midline    
Subtests Mean SD Mean SD df t p 
TMT 42.40 2.19 52.50 5.90 27 1.71 0.10 
BACS 41.68 2.90 57.50 7.80 27 2.03 0.05* 
HVLT 37.40 1.93 41.75 5.20 27 0.84 0.41 
WMS 48.76 2.24 56.50 6.03 27 1.28 0.21 
LNS 39.92 2.64 55.00 6.29 27 2.38 0.02* 
Mazes 46.52 1.84 51.00 4.95 27 0.91 0.37 
BVMT 42.72 2.62 51.75 7.05 27 1.28 0.21 
Fluency 44.76 2.42 50.75 6.51 27 0.92 0.37 
MSCEIT 34.88 2.71 37.25 7.18 26 0.33 0.74 
CPT 34.14 2.38 46.50 5.95 23 2.08 0.05* 
Domains        
SoP 40.60 2.79 54.75 7.50 27 1.89 0.07 
AV 34.14 2.38 46.50 5.95 23 2.08 0.04* 
WM 43.08 2.45 56.75 6.59 27 2.07 0.04* 
VrblLrng 37.40 1.93 41.75 5.20 27 0.84 0.41 
VisLrng 42.72 2.62 51.75 7.05 27 1.28 0.21 
RPS 46.52 1.84 51.00 4.95 27 0.91 0.37 
SC 34.88 2.71 37.25 7.18 26 0.33 0.74 
Comp 33.80 2.91 13.70 7.12 22 1.93 0.07 
Wasi 
Domains 
       
VCI 93.31 3.81 93.50 10.94 31 0.02 0.99 
PRI 97.72 2.81 111.75 8.08 31 1.74 0.09 
Comp 87.31 5.44 77.00 15.63 31 0.66 0.51 
*p<.05        
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Table 20 
Relation of the Presence of Tongue Spots and the Cognitive Variables 
 Not Present Present    
Subtests Mean SD Mean SD df t p 
TMT 42.64 1.37 53.40 4.85 61 2.22 0.03* 
BACS 42.20 1.56 60.20 5.57 62 3.23 0.00* 
HVLT 39.61 1.42 46.20 5.09 62 1.30 0.20 
WMS 49.29 1.64 58.20 5.86 62 1.52 0.13 
LNS 40.75 1.60 47.00 5.71 62 1.10 0.28 
Mazes 46.93 1.23 53.00 4.41 62 1.38 0.17 
BVMT 42.21 1.65 50.80 5.86 61 1.47 0.15 
Fluency 46.25 1.58 55.10 5.65 62 1.76 0.08 
MSCEIT 37.45 2.02 39.00 7.18 61 0.22 0.83 
CPT 38.42 1.38 45.75 5.20 55 1.41 0.16 
Domains        
SoP 41.66 1.49 58.60 5.34 62 3.17 0.00* 
AV 38.42 1.38 45.75 5.20 55 1.41 0.16 
WM 43.93 1.70 53.00 6.08 62 1.49 0.14 
VrblLrng 39.61 1.42 46.20 5.09 62 1.30 0.20 
VisLrng 42.21 1.65 50.80 5.86 61 1.47 0.15 
RPS 46.93 1.23 53.00 4.41 62 1.38 0.17 
SC 37.45 2.02 39.00 7.18 61 0.22 0.83 
Comp 36.41 1.80 47.50 6.68 53 1.66 0.10 
Wasi 
Domains 
       
VCI 91.81 2.31 100.33 7.82 67 1.09 0.28 
PRI 96.27 2.28 106.93 7.74 67 1.36 0.18 
Comp 88.38 3.02 103.83 10.24 67 1.51 0.14 
*p<.05        
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Table 21 
Relation of the Presence of Bifid Tongue and the Cognitive Variables 
 Not Present Present    
Subtests Mean SD Mean SD df t p 
TMT 43.74 1.41 42.17 4.61 63 -0.34 0.73 
BACS 43.64 1.68 44.83 5.52 64 0.22 0.83 
HVLT 40.27 1.44 40.67 4.75 64 0.08 0.93 
WMS 50.08 1.66 50.17 5.46 64 0.02 0.99 
LNS 41.49 1.61 40.50 5.29 64 -0.19 0.85 
Mazes 47.83 1.23 42.50 4.04 64 -1.32 0.19 
BVMT 43.81 1.69 37.50 5.50 63 -1.15 0.26 
Fluency 47.02 1.62 49.17 5.32 64 0.40 0.69 
MSCEIT 37.74 2.02 37.67 6.58 63 -0.01 0.99 
CPT 38.46 1.35 46.00 5.15 57 1.46 0.15 
Domains        
SoP 43.08 1.61 44.00 5.30 64 0.17 0.86 
AV 38.46 1.35 46.00 5.15 57 1.46 0.15 
WM 44.88 1.72 44.00 5.67 64 -0.155 0.88 
VrblLrng 40.27 1.44 40.67 4.75 64 0.08 0.93 
VisLrng 43.81 1.69 37.50 5.50 63 -1.15 0.26 
RPS 47.83 1.23 42.50 4.04 64 -1.32 0.19 
SC 37.74 2.02 37.67 6.58 63 -0.01 0.99 
Comp 37.04 1.82 43.25 6.81 55 0.91 0.37 
Wasi 
Domains 
       
VCI 93.56 2.26 82.19 7.70 68 -1.48 0.14 
PRI 97.47 2.32 99.00 7.93 68 0.19 0.85 
Comp 89.14 3.02 99.50 10.31 68 1.01 0.32 
*p<.05        
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Table 22 
Relation of the Epicanthus Coverage of the Tear Duct and the Cognitive Variables 
 No Coverage of 
Tear Duct 
Partial 
Coverage of 
Tear Duct 
Full Coverage of 
Tear Duct 
   
Subtests Mean SD Mean SD Mean SD df F p 
TMT 44.39 2.67 46.44 5.29 48.46 3.86 2,60 0.71 0.50 
BACS 41.64 3.25 37.20 6.45 42.86 4.65 2,61 0.89 0.42 
HVLT 36.77 2.81 28.77 5.61 34.04 4.03 2,61 1.17 0.32 
WMS 49.13 3.22 46.38 6.40 48.68 4.60 2,61 0.15 0.86 
LNS 37.37 3.04 28.65 6.05 36.87 4.35 2,61 2.03 0.14 
Mazes 46.79 2.45 44.77 4.88 44.68 3.51 2,61 0.18 0.84 
BVMT 40.88 3.30 34.18 6.53 35.64 4.76 2,60 0.66 0.52 
Fluency 43.42 3.18 35.67 6.32 42.35 4.54 2,61 1.25 0.29 
MSCEIT 36.27 3.10 32.27 7.79 32.75 5.70 2,60 0.19 0.82 
CPT 37.90 2.65 34.38 5.20 34.44 3.91 2,54 0.40 0.68 
Domains          
SoP 40.82 3.10 36.00 6.16 42.26 4.43 2,61 1.20 0.31 
AV 37.90 2.65 34.38 5.20 34.44 3.91 2,54 0.40 0.68 
WM 41.73 3.27 34.67 6.50 41.14 4.67 2,61 1.09 0.34 
VrblLrng 36.77 2.81 28.77 5.61 34.04 4.03 2,61 1.17 0.32 
VisLrng 40.88 3.30 34.18 6.53 35.64 4.76 2,60 0.66 0.52 
RPS 46.79 2.45 44.77 4.88 44.68 3.51 2,61 0.18 0.84 
SC 36.27 3.10 32.27 7.79 32.75 5.70 2,60 0.19 0.82 
Comp 34.28 3.39 25.84 6.58 29.85 5.05 2,52 0.82 0.44 
Wasi 
Domains 
         
VCI 93.73 13.22 91.27 13.81 80.00 12.97 2,66 0.61 0.55 
PRI 92.93 13.99 99.42 13.34 88.50 13.09 2,66 0.94 0.39 
Comp 82.50 17.40 90.11 17.73 91.57 18.61 2,66 0.12 0.89 
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Table 23 
Relation of the Strabismus and the Cognitive Variables 
 
Strabismus 
Esotropia 
Strabismus 
Exotropia 
Strabismus     
Hypertropia                   
None 
Present 
   
Subtests Mean SD Mean SD Mean   SD Mean SD df F p 
TMT 38.00 10.99 35.00 15.54 43.00 15.54 43.76 11.08 3,57 0.29 0.83 
BACS 32.00 13.15 48.00 18.59 39.00 18.59 44.10 13.26 3,58 0.36 0.78 
HVLT 24.00 10.90 36.00 15.41 30.00 15.41 40.80 10.99 3,58 1.14 0.34 
WMS 53.00 12.88 67.00 18.22 46.00 18.22 50.05 12.99 3, 
58 
0.62 0.61 
LNS 33.00 12.45 44.00 17.61 39.00 17.61 41.81 12.56 3, 
58 
0.19 0.90 
Mazes 43.00 9.25 52.00 13.08 37.00 13.01 38.51 9.33 3,58 0.58 0.63 
BVMT 23.00 12.45 56.00 17.61 - - 43.81 12.56 2,58 1.87 0.16 
Fluency 36.00 12.36 41.00 17.48 41.00 17.48 47.17 12.46 3,58 0.42 0.74 
MSCEIT - - 29.00 15.37 43.00 21.73 48.46 15.50 2,58 0.23 0.79 
CPT 31.00 10.38 47.00 14.68 42.00 14.68 39.17 10.48 3,51 0.42 0.74 
Domains            
SoP 30.00 12.52 38.00 17.70 38.00 17.70 43.41 12.62 3,58 0.49 0.69 
AV 31.00 10.38 47.00 14.68 42.00 14.68 39.17 10.48 3 51 0.42 0.74 
WM 42.00 13.34 56.00 18.86 41.00 18.86 45.03 13.45 3,58 0.27 0.84 
VrblLrng 24.00 10.90 36.00 15.41 30.00 15.41 40.80 10.99 3,58 1.14 0.34 
VisLrng 23.00 12.45 56.00 17.61 - - 43.81 12.56 2,58 1.87 0.16 
RPS 43.00 9.25 52.00 13.08 37.00 13.08 47.49 9.33 3,58 0.58 0.63 
SC 29.00 15.37 - - 43.00 21.73 38.46 15.50 2,58 0.23 0.79 
Comp - - 42.00 12.95 - - 37.81 13.08 1,51 0.10 0.75 
Wasi 
Domains 
           
VCI 72.50 12.95 73.00 22.43 110.00 22.43 93.05 13.15 3,63 1.49 0.22 
PRI 65.00 12.38 76.00 21.44 99.00 21.44 98.86 12.57 3,63 2.93 0.04* 
Comp 67.00 17.30 72.00 29.96 105.00 29.96 90.44 17.57 3,63 0.89 0.45 
- Missing data 
* p < 0.05 
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Table 24 
Relation of Hypertelorism and the 
Cognitive Variables 
Subtests df r p 
TMT 62 0.10 0.44 
BACS 63 0.19 0.13 
HVLT 63 0.11 0.40 
WMS 63 0.00 0.99 
LNS 63 0.01 0.94 
Mazes 63 0.05 0.71 
BVMT 62 0.07 0.58 
Fluency 63 0.07 0.57 
MSCEIT 62 0.03 0.79 
CPT 56 0.13 0.33 
Domains    
SoP 63 0.09 0.46 
AV 56 0.13 0.33 
WM 63 0.01 0.93 
VrblLrng 63 0.11 0.40 
VisLrng 62 0.07 0.58 
RPS 63 0.05 0.71 
SC 62 0.03 0.79 
Comp 54 0.01 0.91 
Wasi 
Domains 
   
VCI 67 0.15 0.22 
PRI 67 0.01 0.91 
Comp 67 -
0.10 
0.40 
*p<.05    
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Table 25 
Relation of Curvature of the Fifth 
Finger and the Cognitive 
Variables 
Subtests df r p 
TMT 59 0.04 0.77 
BACS 60 0.04 0.74 
HVLT 60 0.12 0.36 
WMS 60 0.11 0.41 
LNS 60 0.12 0.34 
Mazes 60 0.07 0.57 
BVMT 59 0.06 0.65 
Fluency 60 0.05 0.72 
MSCEIT 59 0.04 0.74 
CPT 53 0.06 0.68 
Domains    
SoP 60 0.02 0.89 
AV 53 0.06 0.68 
WM 60 0.00 0.97 
VrblLrng 60 0.12 0.36 
VisLrng 59 0.06 0.65 
RPS 60 0.07 0.57 
SC 59 0.04 0.74 
Comp 51 0.04 0.80 
Wasi 
Domains 
   
VCI 65 0.06 0.61 
PRI 65 0.09 0.44 
Comp 65 0.05 0.71 
*p<.05    
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Table 26 
Relation of Length Proportion of the 3rd 
and 4th Fingers and the Cognitive 
Variables 
Subtests df r p 
TMT 62 0.25 0.04* 
BACS 63 0.11 0.38 
HVLT 63 0.06 0.66 
WMS 63 0.00 0.99 
LNS 63 0.11 0.38 
Mazes 63 0.10 0.44 
BVMT 62 0.01 0.94 
Fluency 63 0.00 0.99 
MSCEIT 62 0.06 0.66 
CPT 56 0.01 0.94 
Domains    
SoP 63 0.15 0.23 
AV 56 0.01 0.94 
WM 63 0.07 0.57 
VrblLrng 63 0.06 0.66 
VisLrng 62 0.01 0.94 
RPS 63 0.10 0.44 
SC 62 0.06 0.66 
Comp 54 0.10 0.46 
Wasi 
Domains 
   
VCI 68 0.03 0.82 
PRI 68 0.26 0.03* 
Comp 68 0.13 0.30 
*p<.05    
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Table 27 
Relation of Difference in the Length of the 
Interior and Lateral Length of the Second 
Toe and the MCCB 
Subtests df r p 
TMT 62 -0.11 0.38 
BACS 63 0.00 0.95 
HVLT 63 -0.01 0.95 
WMS 63 -0.13 0.32 
LNS 63 -0.02 0.89 
Mazes 63 0.11 0.40 
BVMT 62 0.10 0.43 
Fluency 63 0.07 0.60 
MSCEIT 62 0.06 0.65 
CPT 56 -0.14 0.29 
Domains    
SoP 63 -0.07 0.59 
AV 56 -0.14 0.29 
WM 63 -0.08 0.52 
VrblLrng 63 -0.01 0.95 
VisLrng 62 0.10 0.43 
RPS 63 0.11 0.40 
SC 62 0.06 0.65 
Comp 54 -0.07 0.63 
Wasi Domains    
VCI 68 0.04 0.74 
PRI 68 0.07 0.57 
Comp 68 -0.09 0.43 
*p<.05    
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Table 28 
Relation of Difference in the Length of the 
Interior and Lateral Length of the Third 
Toe and the Cognitive Variables 
Subtests df r p 
TMT 62 0.01 0.93 
BACS 63 0.00 1.00 
HVLT 63 0.02 0.84 
WMS 63 0.44 0.27 
LNS 63 0.03 0.81 
Mazes 63 0.01 0.95 
BVMT 62 0.05 0.67 
Fluency 63 0.04 0.75 
MSCEIT 62 -0.07 0.60 
CPT 56 0.04 0.77 
Domains    
SoP 63 0.01 0.93 
AV 56 0.04 0.77 
WM 63 0.10 0.42 
VrblLrng 63 0.02 0.84 
VisLrng 62 0.05 0.67 
RPS 63 0.01 0.95 
SC 62 -0.07 0.60 
Comp 54 0.04 0.75 
Wasi Domains    
VCI 68 0.14 0.24 
PRI 68 0.13 0.30 
Comp 68 -0.05 0.69 
*p<.05    
 
 
  
Running head: Minor Physical Anomalies and Specific Symptoms of Schizophrenia 85 
Table 29 
Relation of Gap between the First and 
Second Toes and the MCCB 
Subtests df r p 
TMT 61 0.30 0.02* 
BACS 62 0.23 0.07 
HVLT 62 0.34 0.01* 
WMS 62 0.38 0.00* 
LNS 62 0.40 0.00* 
Mazes 62 0.32 0.01* 
BVMT 61 0.23 0.07 
Fluency 62 0.04 0.73 
MSCEIT 61 0.39 0.00* 
CPT 55 0.13 0.32 
Domains    
SoP 62 0.24 0.05 
AV 55 0.13 0.32 
WM 62 0.45 0.00* 
VrblLrng 62 0.34 0.01* 
VisLrng 61 0.23 0.07 
RPS 62 0.32 0.01* 
SC 61 0.39 0.00* 
Comp 53 0.51 0.00* 
Wasi 
Domains 
   
VCI 67 0.18 0.14 
PRI 67 0.28 0.02* 
Comp 67 0.14 0.26 
*p<.05    
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Table 30 
Relation of Hair Whorl Direction and Symptom Ratings 
 
Clockwise 
Counter-
Clockwise 
   
 Mean SD Mean SD df t p 
CAPS 5.17 1.10 10.80 3.38 45 1.67 0.10 
PDI 9.64 1.48 13.00 4.67 48 0.72 0.48 
BPRS        
ThotDis 8.84 0.77 9.40 2.39 47 0.23 0.82 
Anergia 6.84 0.49 7.00 1.52 46 0.11 0.92 
Affect 8.77 0.55 8.60 1.71 47 0.10 0.92 
Disorg 4.48 0.29 4.60 0.92 47 0.13 0.89 
*p<.05        
 
Table 31 
Relation of Hair Whorl Presence and Symptom Ratings 
 Not Present Present    
 Mean SD Mean SD df t p 
CAPS 13.00 3.17 5.77 3.34 50 2.17 0.03* 
PDI 20.60 4.50 9.98 4.72 53 2.25 0.03* 
BPRS        
ThotDis 9.17 2.01 8.90 2.13 53 0.13 0.90 
Anergia 8.00 1.25 6.85 1.32 52 0.87 0.39 
Affect 10.83 1.43 8.75 1.51 53 1.37 0.18 
Disorg 5.33 0.80 4.49 0.85 53 0.99 0.32 
*p<.05        
 
Table 32 
Relation of Hair Whorl Count and Symptom Ratings 
 One Whorl Two Whorls    
 Mean SD Mean SD df t p 
CAPS 5.28 1.08 1.00 4.74 36 0.90 0.37 
PDI 10.03 1.51 2.00 6.77 38 1.19 0.24 
BPRS        
ThotDis 8.43 0.70 4.50 3.09 37 1.27 0.21 
Anergia 7.06 0.55 4.00 2.40 36 1.27 0.21 
Affect 8.41 0.51 6.00 2.25 37 1.07 0.29 
Disorg 4.41 0.29 3.00 1.30 37 1.08 0.29 
*p<.05        
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Relation of the Whorl Position and Symptom Ratings 
 Whorl 
Positon Left 
Whorl 
Position 
Midline 
Whorl 
Position Right 
   
 Mean SD Mean SD Mean SD df F p 
CAPS 11.00 3.69 4.39 4.00 7.067 4.16 2,39 1.62 0.21 
PDI 14.25 5.04 8.67 5.45 12.38 5.64 2,41 0.95 0.39 
BPRS          
ThotDis 9.33 1.92 7.21 2.15 12.62 2.32 2,40 5.57 0.01* 
Anergia 6.50 1.24 6.22 1.39 8.62 1.49 2,39 2.69 0.08 
Affect 10.83 1.34 7.54 1.50 10.92 1.63 2,40 5.50 0.01* 
Disorg 6.17 0.77 4.00 0.86 5.15 0.93 2,40 3.88 0.03* 
*p<.05          
 
 
Table 34 
Relation of Head 
Circumference and Symptom 
Ratings 
 df r p 
CAPS 54 0.05 0.71 
PDI 57 0.01 0.92 
BPRS    
ThotDis 57 -0.06 0.67 
Anergia 57 0.01 0.93 
Affect 57 0.05 0.69 
Disorg 57 -0.11 0.43 
*p<.05    
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Table 35 
Relation of Facial Proportions 
and Symptom Ratings 
 df r p 
CAPS 58 0.02 0.87 
PDI 61 0.05 0.71 
BPRS    
ThotDis 61 0.04 0.78 
Anergia 60 -0.06 0.64 
Affect 61 -0.12 0.33 
Disorg 61 0.07 0.59 
*p<.05    
 
Table 36 
Relation of Ear Lobe Attachment and Symptom Ratings 
 Attached Detached    
 Mean SD Mean SD df t p 
CAPS 8.36 1.47 5.51 1.90 60 1.49 0.14 
PDI 12.92 1.94 9.28 2.51 63 1.45 0.15 
BPRS        
ThotDis 9.16 0.93 8.58 1.19 63 0.49 0.62 
Anergia 6.75 0.61 6.98 0.77 62 0.29 0.77 
Affect 8.48 0.69 9.13 0.88 63 0.73 0.47 
Disorg 4.96 0.39 4.44 0.51 63 1.05 0.29 
*p<.05        
 
Table 37 
Relation of Ear Symmetry and 
Symptom Ratings 
 df r p 
CAPS 60 0.10 0.42 
PDI 63 0.12 0.36 
BPRS    
ThotDis 63 -0.05 0.69 
Anergia 62 0.01 0.92 
Affect 63 0.03 0.79 
Disorg 63 -0.09 0.49 
*p<.05    
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Table 38 
Relation of Left Ear Protrusion 
and Symptom Ratings 
 df r p 
CAPS 58 0.13 0.32 
PDI 61 0.13 0.32 
BPRS    
ThotDis 61 0.11 0.38 
Anergia 60 0.24 0.61 
Affect 61 0.11 0.40 
Disorg 61 -0.00 0.99 
*p<.05    
 
Table 39 
Relation of Right Ear Protrusion 
and Symptom Ratings 
 df r p 
CAPS 58 0.14 0.30 
PDI 61 0.16 0.21 
BPRS    
ThotDis 61 0.05 0.69 
Anergia 60 0.13 0.31 
Affect 61 0.08 0.51 
Disorg 61 0.09 0.50 
*p<.05    
 
Table 40 
Relation of the Palatal Shape and Symptom Ratings 
 Steepled w/ 
Flat Apex U-Shaped V-Shaped 
   
 Mean SD Mean SD Mean SD df F p 
CAPS 13.67 4.24 6.55 4.35 0.00 6.69 2,58 2.19 0.12 
PDI 20.33 5.66 10.44 5.81 1.50 8.95 2,61 2.35 0.10 
BPRS          
ThotDis 11.67 2.67 8.79 2.74 4.00 4.22 2,61 1.66 0.19 
Anergia 8.00 1.71 6.97 1.76 4.00 2.71 2,60 1.18 0.32 
Affect 10.00 1.99 8.02 2.04 5.00 3.15 2,61 1.43 0.25 
Disorg 7.00 1.13 4.58 1.16 3.50 1.78 2,61 2.56 0.09 
*p<.05          
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Table 41 
Relation of the Presence of Palatal Ridges and Symptom Ratings 
 Not Present Present    
Mean SD Mean SD df t p 
CAPS 5.54 1.35 6.87 1.86 57 0.72 0.48 
PDI 10.48 1.89 10.42 2.59 60 0.02 0.98 
BPRS        
ThotDis 8.79 0.83 8.69 0.83 60 0.08 0.94 
Anergia 7.19 0.53 6.55 0.77 59 0.82 0.42 
Affect 8.91 0.61 8.69 0.89 60 0.25 0.81 
Disorg 5.00 0.35 4.28 0.50 60 1.64 0.11 
*p<.05        
 
Table 42 
Relation of Palatal Ridge 
Count and Symptom Ratings 
 df r p 
CAPS 29 0.00 0.98 
PDI 31 0.07 0.69 
BPRS    
ThotDis 26 0.05 0.81 
Anergia 26 -0.09 0.65 
Affect 26 0.20 0.29 
Disorg 26 0.03 0.88 
*p<.05    
 
Table 43 
Relation of the Presence of Tongue Furrows and Symptom 
Ratings 
 Not Present Present    
 Mean SD Mean SD df t p 
CAPS 8.21 1.27 4.89 1.86 60 1.79 0.08 
PDI 11.71 1.72 9.68 2.48 63 0.82 0.42 
BPRS        
ThotDis 8.97 0.80 8.66 1.16 63 0.31 0.76 
Anergia 6.88 0.52 6.90 0.75 62 0.03 0.97 
Affect 9.12 0.59 8.61 0.86 63 0.59 0.56 
Disorg 4.85 0.34 4.39 0.49 63 0.94 0.35 
*p<.05        
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Table 44 
Relation of Tongue Furrow Placement and Symptom 
Ratings 
 
Midline 
Non-
Midline 
   
 Mean SD Mean SD df t p 
CAPS 4.92 1.21 6.33 3.70 26 0.38 0.71 
PDI 10.29 1.88 7.33 5.93 28 0.49 0.62 
BPRS        
ThotDis 8.74 0.97 7.75 2.69 29 0.37 0.72 
Anergia 6.85 0.58 7.25 1.60 29 0.25 0.81 
Affect 8.56 0.67 9.00 1.86 29 0.24 0.81 
Disorg 4.22 0.39 5.50 1.09 29 1.17 0.25 
*p<.05        
 
Table 45 
Relation of the Presence of Tongue Spots and Symptom 
Ratings 
 Not Present Present    
 Mean SD Mean SD df t p 
CAPS 6.93 1.01 4.66 3.23 59 0.49 0.48 
PDI 11.03 1.33 7.83 4.33 62 0.74 0.16 
BPRS        
ThotDis 9.14 0.60 6.17 1.97 62 1.51 0.14 
Anergia 7.11 0.39 5.17 1.26 61 1.54 0.13 
Affect 9.10 0.45 7.17 1.48 62 1.31 0.19 
Disorg 4.75 0.26 3.67 0.85 62 1.28 0.21 
*p<.05        
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Table 46 
Relation of the Presence of Bifid Tongue and Symptom 
Ratings 
 Not Present Present    
 Mean SD Mean SD df t p 
CAPS 6.57 0.98 8.00 3.86 60 0.37 0.71 
PDI 10.67 1.29 11.75 5.19 63 0.21 0.84 
BPRS        
ThotDis 8.78 0.60 9.00 2.17 63 0.10 0.92 
Anergia 6.86 0.39 7.00 1.39 62 0.24 0.81 
Affect 8.72 0.44 10.80 1.59 63 1.30 0.19 
Disorg 4.67 0.26 4.20 0.93 63 0.49 0.62 
*p<.05        
 
Table 47 
Relation of the Epicanthus Coverage of the Tear Duct and Symptom Ratings 
 No Coverage of 
Tear Duct 
Partial 
Coverage of 
Tear Duct 
Full Coverage 
of Tear Duct 
   
 Mean SD Mean SD Mean SD df F p 
CAPS 6.28 5.46 7.15 5.74 10.00 5.34 2,58 0.28 0.76 
PDI 10.02 7.23 12.43 7.58 9.50 7.09 2,61 0.32 0.72 
BPRS          
ThotDis 7.98 3.15 10.71 3.30 9.50 3.09 2,61 2.17 0.12 
Anergia 6.57 2.94 6.81 2.87 7.00 2.84 2,60 0.04 0.96 
Affect 8.17 2.37 10.86 2.48 9.50 2.32 2,61 3.69 0.03* 
Disorg 4.42 1.45 4.79 1.52 5.00 1.42 2,61 0.89 0.41 
*p<.05          
 
  
Running head: Minor Physical Anomalies and Specific Symptoms of Schizophrenia 93 
Table 48 
Relation of the Strabismus and Symptom Ratings 
 Esotropia Exotropia Hypertropia None Present  
 Mean SD Mean SD Mean SD Mean SD df F p 
CAPS 0.00 7.41 20.00 10.47 7.00 10.47 6.74 7.47 3,56 1.34 0.27 
PDI 2.00 9.99 19.00 14.14 19.00 14.14 10.66 10.08 3,58 0.71 0.55 
BPRS            
ThotDis 10.50 3.04 7.00 5.27 - - 8.60 3.09 2,60 0.26 0.77 
Anergia 9.00 2.08 5.00 3.59 - - 6.79 2.11 2,59 0.74 0.48 
Affect 10.50 2.44 9.00 4.23 - - 8.80 2.48 2,60 0.23 0.79 
Disorg 7.00 1.33 4.00 2.31 - - 4.47 1.35 2,60 1.79 0.18 
*p<.05            
 
Table 49 
Relation of Hypertelorism and 
Symptom Ratings 
 df r p 
CAPS 59 0.12 0.35 
PDI 62 0.06 0.64 
BPRS    
ThotDis 62 0.12 0.34 
Anergia 61 0.17 0.18 
Affect 62 0.06 0.65 
Disorg 62 -0.11 0.40 
*p<.05    
 
  
Running head: Minor Physical Anomalies and Specific Symptoms of Schizophrenia 94 
Table 50 
Relation of Curvature of the 
Fifth Finger and Symptom 
Ratings 
 df r p 
CAPS 58 0.06 0.63 
PDI 61 0.04 0.75 
BPRS    
ThotDis 60 0.08 0.54 
Anergia 59 -0.09 0.49 
Affect 60 -0.02 0.87 
Disorg 60 -0.10 0.43 
*p<.05    
 
Table 51 
Relation of Length Proportion 
of the 3rd and 4th Fingers and 
Symptom Ratings 
 df r p 
CAPS 60 0.19 0.13 
PDI 63 0.06 0.63 
BPRS    
ThotDis 63 0.11 0.37 
Anergia 62 -0.11 0.37 
Affect 63 0.24 0.06 
Disorg 63 0.32 0.01* 
*p<.05    
 
  
Running head: Minor Physical Anomalies and Specific Symptoms of Schizophrenia 95 
 
Table 52 
Relation of Difference in the 
Length of the Interior and 
Lateral Length of the Second 
Toe and Symptom Ratings 
 df r p 
CAPS 60 0.12 0.35 
PDI 63 0.09 0.48 
BPRS    
ThotDis 63 0.15 0.25 
Anergia 62 0.08 0.51 
Affect 63 0.11 0.36 
Disorg 63 0.15 0.23 
*p<.05    
 
Table 53 
Relation of Difference in the 
Length of the Interior and 
Lateral Length of the Third 
Toe and Symptom Ratings 
 df r p 
CAPS 60 0.14 0.29 
PDI 63 0.14 0.28 
BPRS    
ThotDis 63 0.01 0.96 
Anergia 62 0.00 0.99 
Affect 63 -0.03 0.82 
Disorg 63 -0.05 0.68 
*p<.05    
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Table 54 
Relation of Gap between the 
First and Second Toes and 
Symptom Ratings 
 df r p 
CAPS 59 0.15 0.26 
PDI 62 0.14 0.28 
BPRS    
ThotDis 62 -0.11 0.38 
Anergia 61 -0.03 0.84 
Affect 62 -0.15 0.23 
Disorg 62 0.05 0.72 
*p<.05    
 
Table 55 
Between Group Differences on Measures of Cognition 
 Healthy Controls Patients   
MCCB M SD M SD t(df) p 
SOP 51.67 1.99 37.07 2.548 5.73(68) <0.000* 
AV 42.92 1.96 36.19 2.516 2.67(59) 0.009* 
WM 50.29 2.41 41.95 3.07 2.72(68) 0.008* 
VrblLrng 47.74 1.81 35.72 2.31 5.21(68) <0.000* 
VisLrng 47.630 2.38 39.76 3.05 2.58(67) 0.012* 
RPS 51.07 1.74 44.65 2.22 2.89(68) 0.005* 
SC 43.85 2.81 33.12 3.62 2.97(66) 0.004* 
Comp 45.63 2.37 32.20 3.08 4.36(57) <0.000* 
WASI       
VCI 105.22 2.58 83.68 3.35 6.44(77) <0.000* 
PRI 107.91 2.90 90.02 3.76 4.76(77) <0.000* 
FSIQ 101.47 3.853 82.66 4.99 3.77(77) <0.000* 
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Table 56 
Between Group Differences on Symptom Measures 
 Healthy Controls Patients   
 M SD M SD t(df) p 
CAPS 1.00 1.05 11.14 1.35 7.52(69) <0.000* 
PDI 4.26 1.42 15.91 1.86 6.28(72) <0.000* 
BPRS       
ThotDis 5.04 0.74 11.68 0.93 7.12(69) <0.000* 
Anergia 5.15 0.52 8.14 0.66 4.52(68) <0.000* 
Affect 6.52 0.64 10.91 0.82 5.38(69) <0.000* 
Disorg 3.37 0.38 5.75 0.48 4.97(69) <0.000* 
 
Table 57 
Correlation Coefficients of MPAs  
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
1. WhorlCount                       
2. WhorlPos -0.01                                           
3. WhorlDir -0.07 -0.07                                         
4. HeadCir 0.54* -0.20 0.16                                       
5. FacePor 0.26 -0.11 0.31* 0.08                                     
6. EarLeft 0.20 -0.14 -0.17 0.06 0.39*                                   
7. EarRight 0.13 -0.12 -0.13 0.11 0.34* 0.91*                                 
8. FingPor -0.02 -0.09 -0.04 -0.05 -0.03 0.05 0.07                               
9. FingFifth 0.18 -0.02 -0.14 -0.02 0.15 0.19 0.14 -0.32*                             
10. EarLobes -0.14 -0.07 0.22 -0.04 0.03 0.05 0.05 0.13 -0.09                           
11. EarLeftPro 0.28 -0.05 -0.03 0.17 0.22 0.19 0.18 0.09 -0.09 0.11                         
12. EarRightPro 0.21 -0.21 -0.06 0.06 0.26* 0.26* 0.22 0.16 -0.11 0.13 0.83*                       
13. Epicanth 0.09 -0.03 -0.09 0.03 0.05 -0.02 -0.04 -0.26* 0.03 -0.09 0.02 0.10                     
14. Hypertel -0.24 -0.03 0.08 0.02 -0.07 -0.01 0.05 0.25* -0.19 0.18 0.28* 0.13 -0.22                   
15. Strab -0.05 -0.31* 0.06 0.04 0.11 -0.04 -0.05 0.01 -0.01 0.02 -0.05 -0.02 -0.11 0.11                 
16. PalShape -0.03 -0.20 0.55* 0.10 0.14 0.02 0.02 -0.07 0.00 -0.07 0.10 0.06 -0.03 -0.02 -0.06               
17. RalRidge 0.01 0.20 -0.14 -0.19 0.03 -0.14 -0.13 -0.29* -0.13 -0.23 -0.08 -0.11 0.17 0.03 0.11 -0.11             
18. PalRidgeCnt 0.16 -0.13 -0.05 -0.14 -0.04 -0.23 -0.14 -0.25 0.13 -0.17 0.16 0.08 0.03 0.26 0.02 -0.01 0.32           
19. TonBifid -0.07 0.02 -0.11 -0.22 0.04 0.20 0.18 -0.06 0.13 -0.04 0.01 -0.01 0.02 -0.07 -0.07 -0.07 0.22 -0.11         
20. TonFurPres 0.00 0.12 0.10 -0.10 0.01 0.08 0.05 -0.19 0.03 0.14 0.02 0.05 0.13 -0.11 -0.15 -0.12 0.13 -0.08 0.00       
21. TonFurPlc -0.05 -0.10 -0.11 0.11 -0.23 -0.12 0.03 0.10 0.02 0.26 0.16 0.02 0.16 0.38* -0.07 -0.07 -0.11 0.01 0.17 .c     
22. TonFurrowP 0.20 -0.18 0.39* 0.09 0.31* -0.07 0.04 0.09 -0.09 -0.01 0.11 0.08 -0.04 0.09 -0.08 0.29* -0.07 0.25 -0.10 0.18 0.07   
23. ToeGap -0.27 -0.02 -0.01 -0.06 -0.19 -0.16 -0.16 0.11 -0.09 0.07 -0.10 -0.08 0.07 0.19 0.08 0.11 -0.07 0.06 -0.13 0.05 0.21 -0.03 
*. Correlation is significant at the 0.05 level (2-tailed) 
c. Cannot be computed because at least one of the variables is constant.  
 
 
 
List of Appendices 
APPENDIX A: Measurement of Minor Physical Anomalies 
Measurement of MPAs 
 
Head: 
Hair Whorls:  Whorls cannot be determined_____ 
Present ____ Not Present___  Total number of whorls___  
 Position: midline, left or right 
 Direction of whorls: clockwise or counter-clockwise 
 
Head circumference:___ (measure above the eyes, around the head over the ears) 
 
Glabella to top of philtrum ___mm 
 
Top of philtrum to base of chin: ___mm 
 
Supraorbital ridge: Left ___mm     Right___mm 
 
Palatal Shape: U-shaped (wider, shorter) ___  Steepled w/ flattened apex ___  V-Shaped___ 
  
Palatal Ridges: Present___ Not present___ Number present from the second bicuspid to the back 
of the mouth___ 
 
Malformed ear: Present___ Not present ___ 
 
Ear symmetry: Height of left ear___ mm Height of right ear___mm 
 
Ear placement: ____mm 
 
Ear lobes: Attached___ Detached___  
 
Ear protrusion: Distance from pinna to cranium   Left___ Right___ 
 
Bifid Tongue: Split present___ No split present___ 
 
Epicanthus: No coverage of tear duct___ Partial coverage of tear duct___  
Full coverage of tear duct___ 
 
Hypertelorism: ___mm 
 
Facial height: glabella to top of philtrum (where the columella and philtrum meet) ___ 
 top of philtrum to base of chin___ 
 
Strabismus: Esotropia___ exotropia___ hypertropia___ 
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Furrowed Tongue: Present___ (Midline___, Non-midline___)  Not present___ 
 
Smooth/Rough spots on the tongue: Present___ Not Present___ 
 
Hand: 
 
Curved fifth finger: ___ degrees 
 
Single transverse palmar crease: Present___ Not present___ 
 
Lateral side of index finger: ___mm 
 
Interior side of middle finger: ___mm 
 
Feet: 
 
Second toe length:   lateral ___mm        interior___mm 
 
Third toe length:    lateral ___mm        interior___mm 
 
Webbing between the second and third toe: present___    not present___ 
 
Gap between the first and second toe (widest area):___mm  
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APPENDIX B: Brief Psychiatric Rating Scale
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APPENDIX C: Peter Delusion Inventory
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APPENDIX D: Cardiff Anomalous Perceptions Scale    
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